新女性医学大系 43 婦人科腫瘍の手術療法

出版社： 中山書店
著者：
発行日： 2001-02-05
分野： 臨床医学：外科  >  産婦人科学
ISBN： 9784521543017
電子書籍版： 2001-02-05 （第1版第1刷）
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

36,300 円(税込)

購入する

商品紹介

婦人科腫瘍の手術では、患者の生活様式や年齢、術後のQOLなど、さまざまな事柄を考慮したうえで的確な術式選択が求められる。本書は、多数の手術図と写真を用いて疾患別に術式の適応と手技を詳説し、さらに手術に不可欠な局所解剖を収載した価値ある1冊である。

目次

  • 表紙
  • 執筆者一覧
  • 目次
  • 婦人科腫瘍手術総論
  • I 婦人科腫瘍手術の歴史
  • 1. 子宮頸癌の手術
  • 2. 子宮筋腫の手術
  • 3. 卵巣癌の手術
  • 4. 外陰癌の手術
  • II 内外性器血管・神経・リンパ系の局所解剖
  • 1. 血管系
  • a. 卵巣の動脈
  • b. 卵巣の静脈
  • c. 子宮・膣の動脈
  • d. 内腸骨動脈
  • e. 子宮動脈
  • f. 子宮動脈の枝
  • g. 膣の動脈
  • h. 腸骨静脈と下大静脈
  • i. 子宮と膣の静脈
  • 2. 神経系
  • a. 卵巣の自律神経
  • b. 骨盤神経叢
  • c. 骨盤神経叢と直腸膣中隔
  • d. 骨盤神経叢と中直腸動脈
  • 3. 外陰部の神経と筋
  • 4. リンパ系
  • a. 卵巣動静脈に沿うリンパ経路
  • b. 鼠径リンパ節
  • c. 腸骨リンパ節
  • d. 子宮・膣のリンパ系
  • e. 大動脈傍リンパ節 (傍大動脈リンパ節)
  • 婦人科腫瘍手術各論
  • I 外陰腫瘍の手術
  • A．良性腫瘍
  • 1．疾患の分類 , 特徴
  • 2．Bartholin腺膿瘍
  • 3．充実性腫瘍
  • 4．尖形コンジローマ
  • 5．汗腺腫
  • B．外陰上皮内腫瘍
  • 1．治療法
  • a．局所切除術
  • b．skinning　vulvectomy
  • c．単純外陰切除術
  • d．レーザー手術
  • 2．治療成績
  • 3．経過観察
  • C．外陰癌
  • 1．適応される術式
  • a．単純外陰摘出術
  • b．局所切除術
  • c．根治的腫瘍切除術
  • d．外陰癌根治手術
  • e．骨盤除臓術
  • 2．術式の選択
  • 3．外陰癌根治手術の術式
  • 4．術後合併症
  • II 膣腫瘍の手術
  • A．良性腫瘍
  • 1．膣の解剖
  • 2．分類 , 鑑別診断
  • a．嚢胞性腫瘤の病理学的分類
  • b．嚢胞性腫瘤の鑑別診断
  • c．充実性腫瘤
  • 3．手術法
  • B. 膣上皮内腫瘍
  • 1. 治療法の種類と選択
  • a. 外来での細胞診と組織生検による経過観察
  • b. 薬物療法
  • c. 放射線療法
  • d. 外科的治療
  • 2. 病変を蒸散あるいは変性させる方法
  • a. レーザー蒸散術
  • b. 凍結療法
  • c. 高周波電気凝固術
  • d. 超音波メス
  • 3. 切除療法
  • a. 局所腫瘍切除術
  • b. 膣部分切除術
  • c. 膣全切除術
  • C. 膣癌
  • 1. 膣癌の広がりの評価
  • 2. 手術適応
  • 3. 術前管理
  • 4. 患者本人 , 家族への説明と同意
  • 5. 手術法
  • a. 広汎子宮全摘出術 + 膣 (全 , 部分) 摘出術
  • b. 全 (部分的) 膣壁切除術
  • c. 部分 (全) 膣壁切除術 + 外陰切除術 + 鼠径リンパ節郭清
  • d. 骨盤除臓術
  • e. 膣切除後の造膣術
  • III 子宮頸部腫瘍の手術
  • A. 子宮頸部初期癌
  • 1. 上皮内癌に対する治療法
  • a. 凍結療法
  • b. レーザー蒸散術
  • c. 円錐切除術
  • d. LEEP法
  • e. 光線力学療法
  • f. 単純子宮全摘出術
  • 2. Ia期子宮頸癌の治療法
  • 3. 子宮頸部初期腺癌
  • B. 早期頸癌
  • i. 準広汎子宮全摘出術
  • 1. 概念
  • 2. 歴史的背景
  • 3. 適応
  • 4. 手術手技
  • 5. 術後合併症
  • ii. 広汎子宮全摘出術
  • 1. 手術適応
  • 2. 術前検査と管理
  • 3. 患者本人 , 家族への説明と同意
  • 4. 手術に使用する器具
  • 5. 手術法
  • 6. 膀胱神経の温存法
  • 7. 術中の出血への対応
  • 8. 術後管理
  • C. 進行頸癌
  • i. 超広汎子宮全摘出術
  • 1. 歴史
  • 2. 広汎子宮全摘出術との違い
  • 3. 三林式術式の治療成績とその評価
  • 4. 手術の適応と意義
  • ii. 骨盤除臓術
  • 1. 概念
  • 2. 適応
  • 3. 術式
  • a. 切除範囲による分類
  • b. 術式の概略
  • iii. neoadjuvant chemotherapyと頸癌手術
  • 1. 手術療法前NACの成績
  • 2. 手術療法前NACの適応
  • 3. 手術療法前NACの方法
  • 4. NACの手術術式
  • D. 頸癌手術の術中・術後の合併症とその処置
  • 1. 術中の合併症
  • a. 術中出血
  • b. 膀胱・尿管損傷
  • c. 腸管損傷
  • 2. 術後の合併症
  • a. 術後出血
  • b. 膀胱・直腸機能障害
  • c. 水腎症
  • d. 膀胱・尿管膣瘻
  • e. 下肢・外陰部リンパ浮腫
  • f. リンパ嚢胞
  • g. 骨盤死腔炎
  • h. 尿路感染症
  • i. 血栓・肺塞栓症
  • IV 子宮体部腫瘍の手術
  • A. 良性腫瘍
  • 1. 単純子宮全摘出術
  • a. 腹式単純子宮全摘出術
  • b. 膣式単純子宮全摘出術
  • 2. 子宮膣上部切断術
  • 3. 腹式子宮筋腫核出術
  • 4. 膣式子宮筋腫核出術
  • 5. 子宮内視鏡下子宮筋腫摘除術
  • B. 体癌
  • 1. 手術進行期分類
  • 2. 腹腔内細胞診
  • 3. リンパ節郭清の適応
  • 4. 傍大動脈リンパ節郭清
  • 5. 付属器転移
  • 6. 膣式子宮全摘出術の適応
  • 7. 広汎子宮全摘出術の適応
  • 8. 子宮体癌における手術手技
  • a. 子宮摘出
  • b. 所属リンパ節
  • c. 傍大動脈リンパ節郭清の手技
  • C. 子宮肉腫
  • 1. 治療上の問題点
  • a. 臨床診断上の問題
  • b. 組織型の問題
  • C. 臨床進行期の問題
  • 2. 治療の基本的な考え方
  • 3. 子宮全摘出術と両側付属器摘出術
  • V 卵巣腫瘍の手術
  • A. 良性腫瘍
  • 1. 適応
  • 2. 手術手技
  • a. 付属器摘出術 (卵巣・卵管摘出術)
  • b. 卵巣嚢腫摘出術 (卵巣嚢腫核出術)
  • c. 卵巣楔状切除術
  • 3. 術中迅速病理組織診断
  • B. 卵巣境界悪性腫瘍
  • 1. 定義
  • 2. 上皮性境界悪性腫瘍の臨床的特徴
  • 3. 上皮性境界悪性腫瘍の診断
  • 4. 上皮性境界悪性腫瘍の治療
  • C. 卵巣癌
  • i. 根治手術
  • 1. 基本的概念
  • a. exploration
  • b. cytoreduction
  • 2. 早期卵巣癌の手術
  • 3. 進行卵巣癌の手術
  • a. 術前処置
  • b. 手術操作
  • c. 術後管理
  • ii. 保存手術
  • 1. 適応の条件
  • 2. 手術手技
  • 3. 術後化学療法について
  • 4. 治療後の問題点
  • iii. セカンドルック手術
  • 1. 歴史
  • 2. 目的
  • 3. 手技
  • 4. 成績
  • a. SLO陽性の頻度と陽性例の予後
  • b. SLO陰性の頻度と陰性後の再発
  • 5. second look laparoscopy
  • a. 卵巣癌治療後症例に対するfollow-up LSの成績
  • b. SLLはSLOに代わりうるか
  • iv. 第2次腫瘍縮小手術
  • 1. 定義 , 概念
  • 2. 理論的背景
  • 3. 分類
  • 4. 手術の成績と実際
  • a. interval cytoreductive surgery
  • b. secondary cytoreductive surgery (第2次腫瘍縮小手術 ; 狭義)
  • c. second look operation
  • d. ネオアジュバント (術前) 化学療法後の腫瘍縮小手術
  • D. 胚細胞腫瘍
  • 1. 悪性卵巣腫瘍の手術
  • 2. 胚細胞腫瘍の手術
  • a. 胚細胞腫瘍における化学療法の意義
  • b. 胚細胞腫瘍における手術療法の意義
  • c. 初回手術
  • d. 2次的手術
  • VI 卵管癌の手術
  • 1. 疫学
  • 2. 診断
  • a. 臨床症状
  • b. 画像検査
  • c. 細胞診
  • d. 手術所見 , 病理所見
  • 3. 手術療法
  • a. 従来の術式とその問題点
  • b. 最近の術式とその問題点
  • c. 卵管癌手術の実際
  • VII 絨毛性疾患の手術
  • 1. 胞状奇胎の手術
  • a. 胞状奇胎妊娠掻爬術
  • b. 妊娠中期胞状奇胎妊娠娩出術
  • c. 子宮切開術
  • d. 子宮摘出術
  • e. 胞状奇胎転移巣の手術
  • 2. 侵入奇胎の手術
  • 3. 絨毛癌の手術
  • a. 子宮摘出術
  • b. 開頭術
  • c. 開胸術
  • d. 肝の手術
  • e. 尿管閉塞に対する手術
  • f. 胃腸管への手術
  • g. 膣充填パッキング法
  • h. 多量出血に対する栄養血管の選択的塞栓術
  • VIII 傍大動脈リンパ節生検と郭清
  • 1. 傍大動脈リンパ節
  • 2. 生検と郭清の違い
  • 3. 生検または郭清部位
  • 4. 郭清手技
  • 5. 傍大動脈リンパ節の転移頻度
  • 6. 傍大動脈リンパ節と左前斜角筋リンパ節
  • IX 再建手術
  • 1. 外陰再建術
  • a. 菱形皮弁
  • b. 会陰大腿転位皮弁
  • C. 分層皮膚移植
  • d. 筋皮弁
  • 2. 膣再建術
  • a. McIndoe手術
  • b. Williams手術
  • c. S状結腸を用いた造膣術
  • d. 筋皮弁による造膣術
  • e. 球海綿体筋を用いた膣瘻の修復
  • 3. 骨盤底再建術
  • X 婦人科良性腫瘍と腹腔鏡下手術
  • 1. 歴史的変遷と概念
  • 2. 施行の現況
  • 3. 手術のための準備
  • 4. 卵巣嚢腫摘出術
  • a. 画像所見と適応
  • b. 卵巣嚢腫の内容液吸引器具
  • c. 手術への手順と術式の選択
  • d. 実際の術式-体外法 , SAND法
  • e. 実際の術式-体内法での嚢腫摘出と卵巣摘出
  • f. 偶発症の発生 , 合併症とその対策
  • 5. 子宮摘出術
  • a. 適応と準備
  • b. 必要な器具類
  • c. LAVHの手順
  • d. LAVHの実践的な適応基準と限界
  • e. 合併症とその対策
  • 6. 子宮筋腫摘出術
  • 7. 人工造膣術
  • 8. 遠隔手術 (tele surgery)
  • 9. リンパ節郭清
  • XI 婦人科悪性腫瘍と腹腔鏡下手術
  • 1. 腹腔鏡下進行期診断について
  • 2. 腹腔内診断
  • 3. 後腹膜腔診断
  • 4. 腹腔鏡下補助悪性腫瘍根治術
  • XII 消化管合併症の管理と手術
  • 1. イレウス
  • a. 術後癒着性イレウスの管理
  • b. 麻痺性イレウスの管理
  • c. 癌性イレウスの管理
  • 2. 放射線腸炎
  • 3. 腸瘻
  • 4. 基本的消化管手術手技
  • a. 腸管吻合
  • b. 人工肛門造設
  • c. バイパス術
  • d. 胃瘻造設
  • XIII 尿路系合併症の管理と手術
  • 1. 腫瘍の圧迫・浸潤に伴う尿路系の狭窄や閉塞に対する泌尿器科的な管理
  • a. 導尿ならびに尿道カテーテル留置
  • b. 膀胱瘻の造設
  • c. 尿管ステント留置
  • d. 腎瘻もしくは尿管皮膚瘻の造設
  • 2. 手術損傷に対する処置・管理
  • a. 膀胱損傷
  • b. 尿管損傷
  • 3. 化学療法 (放射線療法) に備えての管理
  • 4. 尿路変向術の適応
  • 5. 放射線性膀胱障害
  • Glossary
  • 索引
  • 和文索引
  • 欧文索引
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

婦人科腫瘍手術総論

P.11 掲載の参考文献
1) Baskett TF:On the Shoulders of Giants:Eponyms and Names in Obstetrics and Gynaecology. 1998, RCOG Press, London
 
2) Ellis H:Operations That Made History. 1996;pp7-16, Greenwich Medical Media. London
 
3) Shingleton HM, Orr JW Jr:Historical aspects, pathogenesis, and epidemiology. Cancer of the Cervix. 1995;pp1-16, JB Lippincott, Philadelphia
 
4) Mikuta JJ:Historical development of radical surgery for cancer of the cervix. Cervical Cancer and Preinvasive Neoplasia (Rubin SC, Hoskins WJ, eds). 1996;pp183-188, Lippincott-Raven, Philadelphia
 
5) 塚本直樹, Homesley HD:アメリカにおける頸癌手術の動向. 図説産婦人科VIEW30, 子宮頸癌の根治手術(矢嶋 聰, 桑原慶紀, 編). 1998;pp20-25, メジカルビュー社, 東京
 
6) Clark JG:Amore radical method for performing hysterectomy for cancer of the uterus. Bull Johns Hopkins Hosp 1895;6:120-124
 
7) Speert H:Obstetric&Gynecologic Milestones Illustrated. 1996, The Parthenon Publishing Group, New York
 
8) Wertheim E:The extended abdominal operation for carcinoma uteri (based on 500 operative case. American Journal of Obstetrics and Diseases of Women and Children 1912;66:169-232
 
9) 山辺 徹:婦人科がん治療学の歴史的展望. 婦人科がん治療学(野田起一郎, 監). 1997;pp4-16, 金原出版, 東京
 
10) 緒方正清:日本産科学史. 1980;pp1401-1402, 霞ヶ関出版, 東京
 
11) 小倉知治, 仲野良介:岡林式子宮頸癌手術. 1983;pp1-9, 永井書店, 大阪
 
12) Okabayashi H:Radical abdominal hysterectomy for cancer of the cervix uteri. Modification of the Takayama operation. Surg Gynecol Obstet 1921;33:335-343
 
13) 三林隆吉:三林術式-腹式超広汎性子宮全摘除術. 現代産科婦人科学大系8E, 子宮頸癌. 1970;pp269-279, 中山書店, 東京
 
14) Meigs JV:Radical hysterectomy with bilateral node dissection. A report of 100 patients operated five or more years ago. Am J Obstet Gynecol 1951;62:854-870
PubMed
15) Brunschwig A:Complete excision of pelvic viscera for advanced carcinoma. Cancer 1948;1:177-183
 
16) 塚本直樹:骨盤除臓術. 新女性医学大系34, 子宮頸部の悪性腫瘍(杉森 甫, 編). 2000;pp277-285, 中山書店, 東京
 
17) Schauta F:Die erweiterte vaginal Totalexstirpation des Uterus bei Kollumkarzinom. 1908, Verlag von Josef SAFAR, Wien, Leipzig
 
18) Mitra S:Extraperitoneal lymphadenectomy and radical vaginal hysterectomy for cancer of the cervix (Mitra technique). Am J Obstet Gynecol 1959;78:191-196
 
19) 明石勝英, 小六義久, ほか:子宮頸癌の腟式広汎子宮全摘術に関する研究, 第3報, 腹膜外血管処理並びにリンパ節郭清の意義について. 日本産科婦人科学会雑誌 1959;11:137-138
 
20) 工藤隆一, 寒河江悟:腟式広汎子宮全摘術. 新女性医学大系34, 子宮頸部の悪性腫瘍(杉森 甫, 編). 2000;pp261-269, 中山書店, 東京
 
21) Piver M, Rutledge F, et al:Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-272
 
22) Sutton C:Hysterectomy:Ahistorical perspective. Hysterectomy (Wood C, Maher PJ, et al, eds). 1997;pp1-22, Bailliere Tindall, London
 
23) Thompson JD, Warshaw J:Hysterectomy. Te Linde's Operative Gynecology (Rock JA, Thompson JD, eds), 8th ed. 1997;pp771-775, Lippincott-Raven, Philadelphia
 
24) Griffiths CT:Surgical treatment of advanced ovarian cancer. Ovarian Cancer (Hudson CN, ed). 1985;pp213-238, Oxford University Press, Oxford
 
25) Meigs JV:Tumors of the Female Pelvic Organs. 1934, Macmillan, New York
 
26) Pemberton FA:Carcinoma of the ovary. Am J Obstet Gynecol 1940;40:751-760
 
27) Munnell EW:Ovarian carcinoma. Predisposing factors, diagnosis and management. Cancer 1952;5:1128-1133
 
28) Munnell EW:The changing prognosis and treatment in cancer of the ovary. Am J Obstet Gynecol 1968;100:790-805
 
29) Munnell EW:Surgical treatment of ovarian carcinoma. Clin Obstet Gynecol 1969;12:980-992
 
30) Hudson CN:A radical operation for fixed ovarian tumours. J Obstet Gynaecol Br Cwlth 1968;75:1155-1160
 
31) Hudson CN, Chir M:Surgical treatment of ovarian cancer. Gynecol Oncol 1973;1:370-378
 
32) Griffiths CT:Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Symposium on ovarian cancer. Nat Cancer Inst Monog 1975;42:101-104
 
33) 塚本直樹:卵巣悪性腫瘍の臨床進行期分類 FIGO. 新女性医学大系36, 卵巣・卵管の悪性腫瘍 (薬師寺道明, 編). 1999;pp185-194, 中山書店, 東京
 
34) Way S:Malignant Disease of the Vulva. 1982, Churchill Livingstone, Edinburgh, London
 
35) Taussig FJ:Cancer of the vulva:An analysis of 155 cases. Am J Obstet Gynecol 1940;40:764-779
 
36) Way S:Carcinoma of the vulva. Am J Obstet Gynecol 1960;79:692-697
 
37) Byron RL, Lamb EJ, et al:Radical inguinal node dissection in the treatment of cancer. Surg Gynecol Obstet 1962;114:401-411
 
38) Hacker NF, Leuchter RS, et al:Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 1981;58:574-579
 
39) Wharton JT, Gallager S, et al:Microinvasive carcinoma of the vulva. Am J Obstet Gynecol 1974;118:159-162
 
40) 塚本直樹:最近の外陰癌の手術療法. Oncology & Chemotherapy 1997;13:207-212
 
41) Homesley HD, Bundy BN, et al:Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986;68:733-740
 
P.44 掲載の参考文献
1) 塚本 登:日本人骨盤内動脈の分岐状態に就て. 解剖学雑誌 1929;2:830-852
 
2) 佐藤健次, 佐藤達夫:陰部神経叢と骨盤神経叢の構成と分布. 日本大腸肛門病学会雑誌 1981;34:515-529
 
3) Woodburne RT:Anatomy of the bladder and bladder outlet. J Urol 1968;100:474-484
 
4) Reiforenstuhl G, Platzer W:Die vaginalen Operationen. 1974;pp34-37, Urban & Schwarzenberg, Munchen
 
5) Rouviere H:Anatomie des lymphatiques de l'homme. 1932;pp295-297, Masson, Paris
 
6) 佐藤健次, 出来尚史, 佐藤達夫:腹大動脈および腎茎周囲のリンパ系と大動脈裂孔との関係について. リンパ学 1988;11:45-55
 

婦人科腫瘍手術各論

P.55 掲載の参考文献
1) Scully RE, Bonfigo TA, et al (eds):Histological Typing of Female Genital Tract Tumours, 2nd ed. 1994;pp64-79, Springer-Verlag, New York
 
2) Horowitz IR, Buscema J, Woodruff JD:Surgical conditions of the vulva. Te Linde's Operative Gynecology (Rock JA, Thompson JD, eds), 8th ed. 1997;pp1065-1124, JB Lippincott-Raven, Philadelphia
 
3) Corson SL, Sedlacek TV, Hoffman JJ:Vulvar operation. Greenhill's Surgical Gynecology (Corson SL, Sedlacek TV, Holfman JJ, eds), 4th ed. 1969;pp56-67, Year Book Medical, Chicago
 
4) Visco AG, Del Priore G:Postmenopausal bartholin gland enlargement:A hospital-based cancer risk assessment. Obstet Gynecol 1996;87:286-290
 
5) Hill DA, Lense JJ:Office management of Bartholin gland cysts and abscesses. Am Fam Physician 1998;57:1611-1616
 
6) Cho JY, Ahn MO, Cha KS:Window operation:An alternative treatment method for Bartholin gland cysts and abscesses. Obstet Gynecol 1990;76:886-888
 
7) Lees DH, Singer A:Surgery of Vulva andower Genital Tract. 1980;pp69-79, Wolfe, London
 
8) Gissmann L, de Villiers EM, zur Hausen H:Analysis of human genital warts (condyloma acuminatum) and other genital tumors for human papillomavirus type 6 DNA. Int J Cancer 1982;29:143-146
 
9) Boshart M, zur Hausen H:Human papillomaviruses in Buschke-Lowenstein tumors:Physical state of the DNA and identification of atandem duplication in the noncoding region of a human papillomavirus 6 subtype. J Virol 1986;58:963-966
 
10) Buschke A, Lowenstein L:Uber carcinomahnliche condylomata Acuminatua. Klinische Wochenschrift 1925;4:1726-1728
 
11) Simmons PD:Podophyllin 10% and 25% in the treatment of ano-genital warts. Br J Vener Dis 1981;57:208-209
 
12) Khawaja HT:Treatment of condyloma acuminatum. Lancet 1986;i:208-209
 
13) Krebs HB:Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesions of the vulva and vagina. Obstet Gynecol 1986;68:837-841
 
14) Reid RR, Greenberg MD, et al:Superficial laser vulvectomy. IV. Extended laser vaporization and adjunctive-fluorouracil therapy of human papillomavirus-assoclated vulvar disease. Obstet Gynecol 1990;76:439-448
 
15) Baggish MS:Carbon dioxide laser treatment for condylomata acuminata venereal infections, Obstet Gynecol 1980;55:711-715
 
16) Reid RR:Superficial laser vulvectomy. I. The efhcacy of extended superficial ablation for reforactory and very extensive condylomas. Am J Obstet Gynecol 1985;151:1047-1052
 
17) Reid RR:Superficial laser vulvectomy. III. A new surgical technique for appendage-conserving ablation reforactory condylomas and vulvar intraepithelial neoplasia. Am J Obstet Gynecol 1985;152:504-509
 
18) 塚本直樹:婦人科領域におけるレーザーの応用. 医学のあゆみ 1983;124:544-549
 
19) Woodworth H, Dockerty MB, et al:Papillary hidradenoma of the vulva. A clinicopathologic study of 69 cases. Am J Obstet Gynecol 1971;110:501-508
 
20) Basta A, Madej JG Jr:Hidradenoma of the vulva. Incidence and clinical observations. Eur J Gynaecol Oncol 1990;11:185-189
 
21) Nielsen NC:Case reports:Hidradenoma of the vulva. Acta Obstet Gynecol Scand 1973;52:387-389
 
22) 本間 滋, 児玉省二, ほか:外陰に発生したpapillary hidradenoma の1例. 日本臨床細胞学会雑誌 1983;22:250-254
 
23) Kaufmann T, Pawl NO, et al:Case report. Cystic papillary hidradenoma of the vulva:Case report and review of the literature. Gynecol Oncol 1987;26:240-245
 
24) Schramm G:Diagnosis of a papillary hidradenoma of the vulva by simultaneous cytology and colposcopy. Acta Cytol 1979;23:57-60
 
25) Fritsches HG, Busch WE:The importance of complementary cytology and colposcopy in a detection program. Acta Cytol 1977;21:10-13
 
P.66 掲載の参考文献
1) Bowen JT:Precancerous dermatosis-A study of chronic atypical epithelial proliferation. J Cut Dis 1912;30:241-255
 
2) Knight RV:Bowen's disease of the vulva. Am J Obstet Gynecol 1943;46:514-524
 
3) Woodruff JD, Hildebrandt EG:Carcinoma in situ of the vulva. Obstet Gynecol 1958;12:414-424
 
4) Scully RE, Bonfiglio TA, et al:Histological Typing of Female Genital Tract Tumours, 2nd ed. 1994;p65, Springer-Verlag, New York
 
5) Hilliard GD, Massey FM, O'Toole RV Jr:Vulvar neoplasia in the young. Am J Obstet Gynecol 1979;135:185188
 
6) McCaughan JS Jr, Schellwas HF, et al:Photodynamic therapy of gynecologic neoplasms after presentation with hematoporphyrin derivative. Lasers Surg Med 1985;5:491-498
 
7) Wheeless CR Jr:Vulva and introitus. Atlas of Pelvic Surgery, 2nd ed. 1988;pp9-27, Lea & Febiger, Philadelphia
 
8) Rutledge F, Sinclair M:Treatment of intraepithelial carcinoma of the vulva by skin excision and graft. Am J Obstet Gynecol 1968;102:806-818
 
9) DiSaia PJ, Rich WM:Surgical approach to multifocal carcinoma in situ of the vulva. Am J Obstet Gynecol 1981;140:136-145
 
10) Leuchter RS, Townsend DE, et al:Treatment of vulvar carcinoma in situ with the CO2 Laser. Gynecol Oncol 1984;19:314-322
 
11) Simonsen EF:CO2 Laser used fbr cancer in situ/Bowen's disease (VIN) and lichen sclerosus in the vulvar region. Acta Obstet Gynecol Scand 1989;68:551-553
 
12) Helmerhorst TJ, van der Vaart CH, et al:CO2-laser therapy in patients with vulvar intraepithe lial neoplasia. Eur J Obstet Gynecol Reprod Biol 1990;34:149-155
 
13) Hoffman MS, Pinelli DM, et al:Laser vaporization for vulvar intraepithelial neoplasia III. J Reprod Med 1992;37:135-137
 
14) Scully RE, Bonfiglio TA, et al:Histological Typing of Female Genital Tract Tumours, 2nd ed. 1994;p69, Springer-Verlag, New York
 
15) Feuer GA, Shevchuk M, Calanog A:Vulvar Paget's disease:The need to exclude an invasive lesion, Gynecol Oncol 1990;38:81-89
 
16) Hawley IC, Husain F, Pryse-Davies J:Extramammary Paget's disease of the vulva with dermal invasion and vulval intraepithelial neoplasia. Histopthology 1991;18:374-376
 
17) Bergen S, DiSaia PJ, et al:Conservative management of extramammary Paget's disease of the vulva. Gynecol Oncol 1989;33:151-156
 
18) Ewing TL:Paget's disease of the vulva treated by combined surgery and laser. Gynecol Oncol 1991;43:137-140
 
P.74 掲載の参考文献
1) Basset A:Traitement chirurgical operatoire ed L'epithelioma primitif du clitoris. Indications, techniques, resultats. Revues Chirurgie (Paris) 1912;46:546-570
 
2) Taussig FJ:Cancer of the vulva. An analysis of 155 cases (1911-1940). Am Obstet Gynecol 1940;40:764-779
 
3) Way S:Carcinoma of the vulva. Am J Obstet Gynecol 1960;79:692-697
 
4) 河野一郎, 藤原恵一, ほか:外陰癌の化学療法. 産婦人科の実際 1999;48:953-958
 
5) Hacker NF:Vulvar cancer. Novak's Gynecology (Berek JS, ed), 12th ed. 1996;pp1231-1259, Williams & Wilkins, Baltimore
 
6) Heaps JM, Fu YS, et al:Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 1990;38:309-314
 
7) Podratz KC, Symmonds RE, Taylor WF:Carcinoma of the vulva:Analysis oftreatment failures. Am J Obstet Gynecol 1982;143:340-351
 
8) Malfetano J, Piver MS, Tsukada Y:Stage III and IV squamous cell carcinoma of the vulva. Gynecol Oncol 1986;23:192-198
 
9) Griffiths CT, Silverstone A, et al:Gynecologic Oncology. 1997, Mosby-Wolfe, London
 
10) Isaacs JH:Verrucous carcinoma of the female genital tract. Gynecol Oncol 1976;4:259-269
 
11) Japase H, Van Dinh TV, Woodruff JD:Verrucous carcinoma of the vulva:Study of 24 cases. Obstet Gynecol 1982;60:462-466
 
12) Vander Velden J, Hacker NF:Update on vulvar carcinoma. Gynecologic Oncology Controversies and New Developments (Rothenberg ML, ed). 1994;pp101-119, Kluwer Academic, Boston
 
13) Homesley HD, Bundy BN, et al:Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 1986;68:733-740
 
14) Hacker NF, Berek JS, et al:Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 1983;61:408-412
 
15) 塚本直樹:外陰癌-根治手術. 臨床婦人科産科 1993;47:756-757
 
16) 玉舎輝彦:外陰の手術とそのコツ. 産婦人科治療 1992;65:662-669
 
17) Morrow CP, Curtin JP, Townsend DE:Synopsis of Gynecologic Oncology, 4th ed. 1993, Churchill Livingstone, New York
 
P.84 掲載の参考文献
1) De Lancey JOL:Surgical anatomy of the female pelvis. Te Linde's Operative Gynecology (Rock JA, Thompson JD, eds), 8th ed. 1997;pp63-93, Lippincott-Raven, Philadelphia
 
2) Pradhan S, Tobon H:Vaginal cysts:A clinicopathological study of 41 cases. Int J Gynecol Pathol 1986;5:35-46
 
3) Deppisch LM:Cysts ofthe vagina:Classification and clinical correlations. Obstet Gynecol 1975;45:632-637
 
4) Silverberg SG, Frable WJ:Prolapse of fallopian tube into vaginal vault after hysterectomy. Histopathology, cytopathology and differential diagnosis. Arch Pathol 1974;97:100-103
 
5) Tavassoli FA, Norris HJ:Smooth muscle tumors of the vagina. Obstet Gynecol 1979;53:689-693
 
6) Ball TL:Benign tumors of the vulva and vagina. Gynecologic Surgery and Urology. 1957;pp239-253, Daisy Stilwell, St Louis
 
7) Rhame RC, Derrick FC Jr:Gartner's duct cyst involving urinary tract. J Urol 1973;109:60-61
 
P.91 掲載の参考文献
1) Cramer D, Cutler S:Incidence and histopathology of malignancies of the female genital organs in the United States. Am J Obstet Gynecol 1974;118:443-460
 
2) Gallup DG, Morley G:Carcinoma in situ of the vagina. Obstet Gynecol 1975;46:334-340
 
3) Muran D, Curry RH, Drovin P:Cytologic follow-up of patients with invasive cervical carcinoma treated by radiotherapy. Am J Obstet Gynecol 1982;142:350-354
 
4) Okagaki T, Twiggs LB, et al:Identification of human papillomavirus in cervical and vaginal intraneoplasia with molecularly cloned virus-specific DNA probes. Int J Gynecol Pathol 1983;2:153-159
 
5) Simpkins PB, Chir B, Hull MGR:Intraepithelial vaginal neoplasia following immunosuppressive therapy treated with topical 5-Fu. Obstet Gynecol 1975;46:360-362
 
6) Geelhoed GW, Henson DE, et al:Carcinoma in situ of the vagina following treatment for carcinoma of the cervix. A distinctive clinical entity. Am J Obstet Gynecol 1976;124:510-516
 
7) 片瀬功芳, 荷見勝彦:腟の悪性腫瘍と関連病変. 新女性医学大系38, 外陰・腟の悪性腫瘍(工藤隆一, 編). 1998;pp255-263, 中山書店, 東京
 
8) Woodruff JD, Parmley TH, Julian CG:Topical 5-fluorouracil in the treatment of vaginal carcinoma-in-situ. Gynecol Oncol 1975;3:124-132
 
9) Caglar H, Herzog RW, Hreshchyshyn MM:Topical 5-fluorouracil treatment of vaginal intraepithelial neoplasia. Obstet Gynecol 1981;58:580-583
 
10) Krebs H-B:Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesions of vulva and vagina. Obstet Gynecol 1986;68:837-841
 
11) Benedet JL, Sanders BH:Carcinoma in situ of the vagina. Am J Obstet Gynecol 1984;148:695-700
 
12) MacLeod C, Fowler A, et al:High-dose-rate brachytherapy in the management of high-grade intraepithelial neoplasia of the vagina. Gynecol Oncol 1997;65:74-77
 
13) Riva JM, Sedlacek TV, et al:Extended carbon dioxide laser vaporization in the treatment of subclinical papillomavirus infection of the lower genital tract Obstet Gynecol 1989;73:25-30
 
14) Stuart GC, Flagler EA, et al:Laser vaporization of vaginal intraepithelial neoplasia. Am J Obstet Gynecol 1988;158:240-243
 
15) Hoffman MS, Roberts WS, et al:Laser vaporization of grade 3 vaginal intraepithelial neoplasia. Am J Obstet Gynecol 1991;165:1342-1344
 
16) Townsend DE, Levin RU, Richart RM:Treatment of vaginal carcinoma in situ with carbon dioxide laser. Am J Obstet Gynecol 1982;143:565-568
 
17) Lenehan PM, Meffe F, Lickrish GM:Vaginal intraepithelial neoplasia:Biologic aspects and management. Obstet Gynecol 1986;68:333-337
 
18) Hoffman MS, DeCesare SL, et al:Upper vaginectomy for in situ and occult, superficially invasive carcinoma of the vagina. Am J Obstet Gynecol 1992;166:30-33
 
19) Curtis P, Shepherd JH, et al:The role of partial colpectomy in the management of persistent vaginal neoplasia after primary treatment. Br J Obstet Gynaecol 1992;99:587-589
 
20) Cheng D, Ng TY, et al:Wide local excision (WLE) for vaginal intraepithelial neoplasia (VAIN). A cta Obstet Gynecol Scand 1999;78:648-652
 
21) Ireland D, Monaghan JM:The management of the patient with abnormal vaginal cytology following hysterectomy. Br J Obstet Gynaecol 1988;95:973-975
 
22) Woodman CBJ, Jordan JA, Wade-Evans T:The management of vaginal intraepithelial neoplasia after hysterectomy. Br J Obstet Gynaecol 1984;91:707-711
 
23) Peters WA III, Kumar NB, Morley GW:Carcinoma of the vagina:Factors influencing treatment results, Cancer 1985;55:982-987
 
24) 古谷健一, 永田一郎:上皮性・非上皮性悪性腫瘍-手術療法を中心に. 新女性医学大系38, 外陰・腟の悪性腫瘍(工藤隆一, 編). 1998;pp264-272, 中山書店, 東京
 
25) Wheeless CR Jr:Total vaginectomy. Atlas of Pelvic Surgery, 3rd ed. 1997;p402, Williams & Wilkins, Baltimore
 
P.100 掲載の参考文献
1) Benedet JL, Murphy KJ, et al:Primary invasive carcinoma of the vagina. Obstet Gynecol 1983;62:715-719
 
2) Eddy GL, Marks RD, et al:Primary invasive vaginal carcinoma. Am J Obstet Gynecol 1991;165:292-298
 
3) Rubin SC, Young J, Mikuta JJ:Squamous cell carcinoma of the vagina:Treatment, complications, and long-term follow-up. Gynecol Oncol 1985;20:346-353
 
4) Dixit S, Singhal S, Baboo HA:Squamous cell carcinoma of the vagina:A review of 70 cases. Gynecol Oncol 1993;48:80-87
 
5) Houghton CRS, Iversen T:Squamous cell carcinoma of the vagina:A clinical study of the location of the tumor. Gynecol Oncol 1982;13:365-372
 
6) Monaghan JM:Invasive tumors of vagina:Clinical features and management. Gynecologic Oncology (Coppleson M, ed), 2nd ed, vol 1. 1992;pp505-519, Churchill Livingstone, Edinburgh
 
7) Hoffman MS, DeCesare SL, et al:Upper vaginectomy for in situ and occult, superficially invasive carcinoma of the vagina. Am J Obstet Gynecol 1992;166:30-33
 
8) Peters WA, Kumar NB, Morley GW:Microinvasive carcinoma of the vagina:Adistinct clinical entity? Am Obstet Gynecol 1985;153:505-507
 
9) Eddy GL, Singh KP, Gansler TS:Superficially invasive carcinoma of the vagina following treatment for cervical cancer:A report of six cases, Gynecol Oncol 1990;36:376-379
 
10) 齋藤俊章, 塚本直樹:上皮性悪性腫瘍-手術療法. 新女性医学大系38, 外陰・腟の悪性腫瘍 (工藤隆一, 編). 1998;pp107-129, 中山書店, 東京
 
11) Senekjian EK, Frey K, Herbst AL:Pelvic exenteration in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol 1989;34:413-416
 
12) Geisler JP, Look KY, et al:Pelvic exenteration for malignant melanomas ofthe vagina or urethra with over 3mm of invasion. Gynecol Oncol 1995;59:338-341
 
13) 塚本直樹:骨盤除臓術. 新女性医学大系34, 子宮頸部の悪性腫瘍(杉森 甫, 編). 2000;pp277-285, 中山書店, 東京
 
14) Beemer W, Hopkins MP, Morley G:Vaginal reconstruction in gynecologic oncology. Obstet Gynecol 1988;72:911-914
 
P.116 掲載の参考文献
1) 西村正人, 古本博孝, 青野敏博:Conizationの実際. 臨床婦人科産科 2000;54:772-776
 
2) Creasman WT:Editorial, new gynecologic cancer staging. Gynecol Oncol 1995;58:157-158
 
3) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約, 改訂第2版. 1997, 金原出版, 東京
 
4) Rock JA, Thompson JD, et al:Te Linde's Operative Gynecology, 8th ed. 1997, Lippincott-Raven, Philadelphia
 
5) Ferenczy A:Comparison of cryo-and carbon dioxide laser therapy for cervical intraepithelial neoplasia. Obstet Gynecol 1985;66:793-798
 
6) Stafl A, Wilkinson EJ, Mattingly RF:Laser treatment of cervical and vaginal neoplasia. Am J Obstet Gynecol 1977;128:128-136
 
7) 落合和徳, 藤井信吾, 桑原慶紀:円錐切除術/LEEP法. 産科と婦人科 1996;63:311-318
 
8) 倉智敬一(編著):子宮腟部円錐切除術とSturmdorf縫合. 図説婦人科基本手術. 1984;pp73-77, 世界保健通信社, 大阪
 
9) Tabor A, Berget A:Cold-knife and Laser conization for cervical intraepithelial neoplasia. Obstet Gynecol 1990;76:633-635
 
10) Kristensen GB, Jenson LK, et al:A randomized trial comparing two methods of cold knifeconization with laser conization. Obstet Gynecol 1990;76:1009-1013
 
11) Delmore J, Horbelt DV, et al:Cervical conization:Cold knife and laser excision in residency training. Obstet Gynecol 1992;79:1016-1019
 
12) Tchabo JG, Thomure MF, et al:A comparison of laser and cold knife conization. Int Surg 1993;78:131-133
 
13) Oyesanya OA, Amerasinghe C, et al:A comparison between loop diathermy conization and cold-knife conization for management of cervical dysplasia associated with unsatisfactory colposcopy. Gynecol Oncol 1993;50:84-88
 
14) Jahshan AE, Kent HL, et al:Hot-knife conization of the cervix:Clinical and pathologic findings forom a study introducing a new technique. Obstet Gynecol 1994;83:97-103
 
15) Girardi F, Heydarfadai M, et al:Cold-knife conization versus loop excision:Histopathologic and clinical results of a randomized trial. Gynecol Oncol 1994;55:368-370
 
16) Mathevet P, Dargent D, et al:A randomized prospective study comparing three techniques of conization:Cold knife, laser, and LEEP. Gynecol Oncol 1994;54:175-179
 
17) 永田尚夫, 佐藤和雄:レーザー治療の進歩. 産科と婦人科 1992;59:501-508
 
18) 脇田邦夫, 泉 貴文, ほか:子宮頸部腫瘍に対するYAGとCO, レーザー円錐切除術の比較検討. 日本産科婦人科学会雑誌 1992;44:1142-1148
 
19) 藤原 潔, 岡部一裕, 高山雅臣:CINおよび子宮頸部微小浸潤癌に対するLoop Electrosurgical Excision Procedure(LEEP)による治療法の検討. 産婦人科手術 1996;7:39-44
 
20) Dougherty TJ, Lawrence G, et al:Photoradiation in the treatment oforecurrent breast carcinoma. J Natl Cancer Inst 1979;62:231-237
 
21) 室谷哲弥, 川崎恵子, ほか:子宮頸部初期病変に対する治療-特に妊孕性温存を目的として-光線力学的治療(PDT:Photodynamic Therapy) による方法. 産科と婦人科 1999;66:1163-1170
 
22) Creasman WT, Fetter BF, et al:Management of Ia carcinoma of the cervix. Am J Obstet Gynecol 1985;153:164-212
 
23) Simon NL, Core H, et al:Study of superficially invasive carcinoma. Obstet Gynecol 1986;68:19:24
 
24) Ueki M, Okamoto Y, et al:Conservative therapy for microinvasive carcinoma of the cervix. Gynecol Oncol 1994;53:109-113
 
25) Tseng seng C-J, Horng S-G, et al:Conservative conization for microinvasive carcinoma of the cervix. J Am J Ohstet Gynecol 1997;176:1109-1110
 
26) Morris M, Mitchell MF, et al:Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix. Gynecol Oncol 1993;51:196-200
 
27) Copeland LJ, Silva EG, et al:Superficially invasive squamous carcinoma of the cervix. Gynecol Oncol 1992;45:307-312
 
28) 日本産科婦人科学会:婦人科腫瘍委員会報告-昭和61年度子宮頸癌患者年報. 日本産科婦人科学会雑誌 1992;44:1487. 1514
 
29) 日本産科婦人科学会:婦人科腫瘍委員会報告-1995年度子宮頸癌患者年報. 日本産科婦人科学会雑誌 2000;52:835-876
 
30) 塩田 充, 小川誠司, ほか:子宮頸癌Ia期(新規約/新進行期分類)臨床的取扱いについて. 産科と婦人科 1998;65:1141-1145
 
31) 加藤久盛, 土井大祐, ほか:子宮頸癌Ia期(新規約)の臨床的取扱いについて-新FIGO分類による子宮頸癌Ia1期, Ia2期の臨床的取扱いについての検討. 産科と婦人科 1998;65:1147-1152
 
32) 沼 文隆, 末広 寛, ほか:子宮頸癌Ia期(新規約)の臨床的取扱いについて-子宮頸癌Ia期の新FIGO分類(Ia1, Ia2)について. 産科と婦人科 1998;65:1155-1159
 
33) 竹島信宏, 矢納研二, ほか:子宮頸癌Ia期(新規約)の臨床的取扱いについて-新FIGO Ia期子宮頸部扁平上皮癌の取扱い. 産科と婦人科 1998;65:1160-1165
 
34) National Institute of Health Consensus Development Conference statement on cervical cancer. Gynecol Oncol 1997;66:351-361
 
35) 蔵本博行, 角田新平, ほか:子宮頸癌I期の新FIGO分類と旧日産婦分類との比較. 産婦人科の世界 1998;50:523-531
 
36) 岩坂 剛:子宮頸癌Ib期のFIGO新分類(Ib1, Ib2)について-臨床的意義と問題点について. 産科と婦人科 1997;57:126-1266
 
37) Brown LJR, Wells M:Cervical glandular atypia associated with squamous intraepithelial neoplasia:A premalignant lesion? J Clin Pathol 1986;39:22-28
 
38) Casper GR, Ostor AG, Quinn MA:A clinicopathologic study of the glandular dysplasia of the cervix. Gynecol Oncol 1997;64:166-170
 
39) 寒河江悟, 福中規功, ほか:初期子宮頸部腺癌の病理と臨床. 産科と婦人科 1997;64:1215-1222
 
40) 中島徳郎:CIN(子宮頸部上皮内腫瘍)の取り扱い. 子宮頸部腫瘍の診断と治療(森 崇英, 小西郁生, ほか, 編). 1996;pp12-125, 永井書店, 大阪
 
41) Poynor EA, Barakat RR, et al:Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1995;57:158-164
 
42) Im DD, Duska LR, et al:Adequacy ofconization margins in adenocarcinoma in situ ofthe cervix as a predictor of residual disease. Gynecol Oncol 1995;59:179-182
 
43) Widrich T, Kennedy AW, et al:Adenocarcinoma in situ of the uterine cervix:Management and outcome. Gynecol Oncol 1996;61:304-308
 
44) Wolf JK, Levenbacl C, et al:Adenocarcinoma in situ of the cervix:Significance of cone biopsy margins. Obstet Gynecol 1996;88:82-86
 
45) 吉岡忠亮, 堂国日子, ほか:初期子宮頸部腺癌の病理と臨床. 産科と婦人科 1997;64:1225-1239
 
46) 加来恒壽, 坂井邦裕, ほか:初期子宮頸部腺癌の病理と臨床. 産科と婦人科 1997;64:1240-1244
 
47) Ostor A, Rome R, et al:Microinvasive adenocarcinoma of the cervix:A clinicopathologic study of 77 women. Obstet Gynecol 1997;89:88-93
 
P.125 掲載の参考文献
1) 杉森 甫, 滝 一郎:子宮頸癌Ia期に対する手術手技. 産科と婦人科 1975;42:79-797
 
2) Piver MS, Rutledge F, Smith JP:Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-272
 
3) Papanicolaou GN, Traut HF:Diagnosis of Uterine Cancer by Vaginal Smear. 1943, Commonwealth Fund, New York
 
4) Mestwerdt G:Die Fruhdiagnoses des Kollumkarzinoms. Zentralbl Gynakol 1947;69:198-202
 
5) Kottmeier HL:Annual Report on the Result of Treatment in Carcinoma of the Uterus and Vagina, vol 14. 1967, Stockholm
 
6) Creasman WT:New gynecologic cancer staging. Gynecol Oncol 1995;58:157-158
 
7) Noda K, Taki I, et al:A new proposal regarding criteria for stage Ia cancer in the uterine cervix. Gynecol Oncol 1979;8:353-369
 
8) 橋本 清:カルチAT. 子宮頸癌0期, Ia期に対して行なう腹式準広汎性子宮全摘出術術式. 産婦人科治療 1971;22:622-633
 
9) 山辺 徹:初期子宮頸癌の手術. 産婦人科治療 1977;35:35-40
 
10) 東 政弘:準広汎子宮全摘術. 子宮頸部の悪性腫瘍. 新女性医学大系34, 子宮頸部の悪性腫瘍 (杉森 甫, 編). 2000;pp253-260, 中山書店, 東京
 
11) Kolstad P, Klem V:Long-term follow up of 1,121 cases of carcinoma in situ. Obstet Gynecol 1976;48:125-129
 
12) 松浦祐介, 柏村正道:早期子宮頸癌の保存的治療. 癌の臨床 1997;43:1205-1211
 
13) 塚本直樹, 松山敏剛, ほか:子宮頸癌Ia期に対する単純子宮全摘術. 日本癌治療学会誌 1985;20:2041-2046
 
14) 角田 肇, 佐藤豊実, ほか:子宮頸癌Ia期の縮小手術に関する検討-単純子宮全摘を採用するにあたって. 日本癌治療学会誌 1993;28:1795-1800
 
15) Kolstad P:Follow up study of 232 patients with stage Ia1 and 411 patients with stage Ia2 squamous cell carcinoma of the cervix (microinvasive carcinoma. Gynecol Oncol 1989;33:265-272
 
16) Copeland LJ, Silva EG, et al:Superficially invasive squamous cell carcinoma of the cervix. Gynecol Oncol 1992;45:307-312
 
17) Yang YC Chang CL:Modified radical hysterectomy for early Ib cervical cancer. Gynecol Oncol 1999;74:241-244
 
18) 植木 健, 久布白兼行, ほか:第39回子宮癌研究会学術集会抄録, シンポジウム-子宮頸癌Ia2の診断と治療-保存的治療は可能か? 1999
 
19) Magrina JF, Goodrich MA, et al:Modified radical hysterectomy in the treatment of early squamous cervical cancer. Gynecol Oncol 1999;72:183-186
 
20) 塚本直樹, 杉森 甫, ほか:子宮頸癌に対する術前照射の検討. 日本産科婦人科学会雑誌 1978;30:691-697
 
21) Morrow CP, Curtin JP:Surgery for cervical neoplasia. Gynecologic Cancer Surgery (Morrow CP, Curtin JP, eds). 1996;pp497-499, Churchill Livingstone, New York
 
22) Tsukamoto N, Kaku T, et al:The problem of stage Ia (FIGO, 1985):Carcinoma of the uterine cervix. Gynecol Oncol 1989;34:1-6
 
23) Photopulos GJ, Zwaag RV:Class II radical hysterectomy shows less morbidity and good treatment efficacy compared to class III, Gynecol Oncol 1991;40:21-24
 
24) Magrina JF, Goodrich MA, et al:Modified radical hysterectomy:Morbidity and mortality. Gynecol Oncol 1995;59:277-282
 
P.142 掲載の参考文献
1) Mikuta JJ:Historical development of radical surgery for cancer of the cervix. Cervical Cancer and Preinvasive Neoplasia (Rubin SC, Hoskins WJ, eds). 1996;pp183-188, Lippincott-Raven, Philadelphia
 
2) Wertheim E:The extended abdominal operation for carcinoma uteri(based on 500 operative cases). American. Journal of Obstetrics and Diseases of Women and Children 1912;66:169-232
 
3) Okabayashi H:Radical abdominal hysterectomy for cancer of the cervix uteri. Modification of the Takayama operation. Surg Gynecol Obstet 1921;33:335-343
 
4) Clark JG:Amore radical method for performing hysterectomy for cancer of the uterus. Bull Johns Hopkins Hosp 1895;6:120-124
 
5) Meigs JV:Radical hysterectomy with bilateral node dissection. A report of 100 patients operated five or more years ago. Am J Obstet Gynecol 1951;62:854-870
PubMed
6) 真柄正直:子宮頸癌の手術. 1974, 金原出版, 東京
 
7) 小倉知治, 仲野良介:岡林式子宮頸癌手術. 1983, 永井書店, 大阪
 
8) 塚本直樹, Homesley HD:アメリカにおける頸癌手術の動向. 図説産婦人科VIEW 30, 子宮頸癌の根治手術(矢嶋 聰, 桑原慶紀, 編). 1998;pp20-25, メジカルビュー社, 東京
 
9) 塚本直樹, 嘉村敏治, ほか:婦人科腫瘍に対するstaging laparotomy. 産婦人科治療 1990;60:121-127
 
10) 塚本直樹:広汎全摘-リンパ節郭清. 臨床婦人科産科 1993;47:180-182
 
11) 塚本直樹:広汎性子宮全摘出術-靱帯処理はここがポイント. 産婦人科の実際 1997;46:1585-1590
 
12) 塚本直樹:婦人科手術における一時的膀胱瘻術. 産婦人科治療 1989;58:138-144
 
13) 植田国昭:広汎子宮全摘術. 新女性医学大系34, 子宮頸部の悪性腫瘍(杉森 甫, 編). 2000;pp238-252, 中山書店, 東京
 
14) 桑原慶紀, 鈴木正明:膀胱子宮靱帯の処理. 図説産婦人科VIEW30, 子宮頸癌の根治手術(矢嶋 聰, 桑原慶紀, 編). 1998;pp106-119, メジカルビュー社, 東京
 
P.149 掲載の参考文献
1) 三林隆吉:三林術式. 現代産科婦人科学大系8E, 子宮頸癌. 1970;pp269-279, 中山書店, 東京
 
2) 東條伸平:子宮頸癌の基本手術. 1981;pp109-120, 永井書店, 大阪
 
3) 小林 隆:子宮頸癌手術. 1961;pp357-384, 南山堂, 東京
 
4) 三林隆吉:岡林式子宮頸癌手術の真髄は何か. 日本産科婦人科学会雑誌 1958;10:657-661
 
5) 八木日出雄:子宮頸癌手術の真髄-岡林式と三林式の諸問題. 日本産科婦人科学会雑誌 1958;10:929-937
 
6) 村上 清:八木教授の「子宮頸癌手術の真髄」を読みて. 日本産科婦人科学会雑誌 1958;10:1623-1626
 
7) 三林隆吉:京都大学婦人科教室に於ける子宮頸癌治療成績(昭和28年度). 日本産科婦人科学会雑誌 1959;11:1003-1006
 
8) 西村敏雄:三林式超広汎性子宮頸癌根治手術術式による治療成績. 日本癌治療学会誌 1966;1:211-214
 
9) 増淵一正:子宮癌診療の回顧. 癌の臨床 1983;29:1041-1047
 
10) Monaghan J:Time to add radiotherapy for cervical cancer. Lancet 1999;353:1288-1289
 
11) Rose PG, Bundy BN, et al:Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153
 
P.159 掲載の参考文献
1) Brunschwig A:Complete excision of pelvic viscera for advanced carcinoma. Cancer 1948;1:177-183
 
2) Mattingly RF, Thompson JD:Te Linde's Operative Gynecology, 6th ed. 1985;pp822-844. Lippincott, Philadelphia
 
3) Appleby RH:Proctocystectomy:The management of colostomy with ureteral transplantation. Am J Surg 1950;79:57-60
 
4) Bricker EM:Bladder substitution after pelvic evisceration. Surg Clin North Am|950;30:1511-1521
 
5) Matthews CM, Morris M, et al:Pelvic exenteration in the elderly patient. Obstet Gynecol 1992;79:773-777
 
6) 田村 学:Pelvic exenteration. 婦人科がん治療学(野田起一郎, 監). 1997;pp303-326, 金原出版, 東京
 
7) Symmonds RE, Pratt JH, Webb MJ:Exenterative operations:Experience with 198 patients. Am J Obstet Oynecol 1975;121:907-918
 
P.165 掲載の参考文献
1) FIGO:Annual Report on the Results of Treatment in Gynecological Cancer (Petterson F, ed), vol 23. 1998;pp29-43
 
2) 日本産科婦人科学会婦人科腫瘍委員会:第35回治療年報. 日本産科婦人科学会雑誌 1998;50:278-305
 
3) Thomas GM:Is neoadjuvant chemotherapy a useful strategy for the treatment of stage Ib cervix cancer? Gynecol Oncol 1993;49:153-155
 
4) Edelmann DZ, Anteby SO:Neoadjuvant chemotherapy for locally advanced cervical cancer-Where does it stand?:A review. Obstet Gynecol Surv 1996;51:305-313
 
5) Souhami L, Gil RA, et al:A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIb carcinoma of the cervix. J Clin Oncol 1991;9:970-977
 
6) Tattersall MH, Lorvidhaya V, et al:Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association. J Clin Oncol 1995;13:444-451
 
7) Sund for K, Trope CG, et al:Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study ofsequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Cancer 1996;77:2371-2378
 
8) Kumar L, Grover R, et al:Neoadjuvant chemotherapy in locally advanced cervical cancer:Two randomized studies. A ust NZ J Med 1998;28:387-390
 
9) Sardi JE, Gialoru A, et al:Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix:The final results. Gynecol Oncol 1997;67:61-69
PubMed
10) Namkoong SE, Park JS, et al:Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy. Gynecol Oncol 1995;59:136-142
 
11) Sardi JE, Gialoru A, et al:Randomized trial with neoadjuvant chemotherapy in stage IIIb squamous carcinoma cervix uteri:An unexpected therapeutic management. Int J Gynecol Cancer 1996;6:85-93
 
12) Eddy GL:Neoadjuvant chemotherapy before surgery in cervical cancer. Monogr Natl Cancer Inst 1996;21:93-99
 
13) Benedetti-Panici P, Greggi S, et al:Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Eur J Cancer 1998;34:341-346
 
14) Scarabelli C, Zarrelli A, et al:Multimodal treatment with neoadjuvant intraarterial chemotherapy and radical surgery in patients with stage IIIb-IVa cervical cancer. A preliminary study Cancer 1995;76:1019-1026
 
15) Minagawa Y, Kigawa J, et al:Radical surgery following neoadjuvant chemotherapy for patients with stage IIIb cervical cancer. Ann Surg Oncol 1998;5:539-543
 
16) Thigpen T, Shingleton H, et al:Cis-dichlorodiammineplatinum (II) in the treatment of gynecologic malignancies:Phase II trials by the Gynecologic Oncology Group. Caneer Treat Rep 1979;63:1549-1555
 
17) Bonomi P, Blessing JA, et al:Randomized trials of three cisplatin dose schedules in squamouscell carcinoma of the cervix:A Gynecologic Oncology Group study. J Clin Oncol 1985;3:1079-1085
 
18) Thigpen T, Vance R, et al:Chemotherapy for advanced or recurrent gynecologic cancer. Cancer 1987;60:2104-2116
 
19) Palo GM de, Bajetta E, et al:Methotrexate and bleomycin in the treatment of advanced epidermoid carcinoma of the uterine cervix. Cancer Chemother Rep 1973;57:429-435
 
20) Malkasian GD Jr, Decker DG, Jorgensen EO:Chemotherapy of carcinoma of the cervix. Gynecol Oncol 1977;5:109-120
 
21) Meanwell CA, Mould JJ, et al:Phase II study of ifosfamide in cervical cancer. Cancer Treat Rep 1986;70:727-730
 
22) Vermorken JB:The role of chemotherapy in squamous cell carcinoma of the uterine cervix:A review. Int J Gynecol Cancer 1993;3:129-142
 
23) 清水敬生, 荷見勝彦:子宮頸癌に対するNeoadjuvant chemotherapy-進行子宮頸部腺癌に対するNeoadjuvant chemotherapyの有用性. 産科と婦人科 1993;60:1315-1324
 
24) Park SY, Kim JH, et al:Phase III randomized study of MVC intraarterial, or systemic neoadjuvant chemotherapy versus radiation therapy only for stage IIb bulky carcinoma of uterine cervix:Preliminary report (meeting abstract). Proc Annu Meet Am Soc Clin Oncol 1996;15:A840
 
25) Piver MS, Rutledge FF, et al:Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974;44:265-272
 
26) Morris M, Eifel PJ, et al:Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer, N Engl J Med 1999;340:1137-1143
 
27) Rose PG, Bundy BN, et al:Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153
 
28) Keys HM, Bundy BN, et al:Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage Ib cervical carcinoma. N Engl Med 1999;340:1154-1161
 
29) Whitney CW, Sause W, et al:Randomized comparison of fiuorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes:A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-1348
 
P.176 掲載の参考文献
1) 田辺達三:血管外傷.一般外科医のための血管の処置と応用手技(田辺達三, 編). 1985;pp200-204, 医学書院, 東京
 
2) 岩井武尚:手術時の血管損傷. 産婦人科の実際 1998;47:1767-1771
 
3) 工藤尚文:術中の大出血. 産婦人科治療 1993;66:897-900
 
4) 関場 香:広汎性子宮全摘出時の対策. 産婦人科の実際 1983;32:325-330
 
5) 村石 修:膀胱・尿管損傷-修復はここがポイント. 産婦人科の実際 1997;46:1745-1751
 
6) 三浦一郎, 東原英二:手術時の尿路損傷(尿管, 膀胱). 産婦人科の実際 1998;47:1761-1766
 
7) 澤田俊夫:手術時の腸管損傷. 産婦人科の実際 1998;47:175-1759
 
8) 関場 香, 石井良夫:子宮癌手術の術前・術後管理. 産婦人科MOOK 24, 術前・術後管理(蜂屋祥一, 編). 1983;pp 162-173, 金原出版, 東京
 
9) 井口厚司:膀胱・尿管腟瘻(婦人科手術後に発生した). 産科と婦人科 1992;59:260-262
 
10) Chodak GW, Plant NE:Wound infections and systemic antibiotic prophylaxis in gynecologic surgery. Obstet Gynecol 1978;51:123-127
 
11) 保田仁介:抗菌剤の予防的投与. 産婦人科における薬物療法(岡田弘二, 編). 1991;pp235-238, 医薬ジャーナル社, 大阪
 
12) 三重野龍彦, 北村 諭:肺血栓・塞栓-最近の動き-我が国の実態. 呼吸と循環 1989;37:932:936
 
13) 雨宮 章:術後血栓塞栓症. 日本産科婦人科学会雑誌 1995;47:N115-N120
 
14) Fraser JD, Anderson DR:Deep venous thrombosis:Recent advances and optimal investigation with US. Radiology 1999;211:9-24
 
15) 小西秀樹, 水谷靖司, ほか:婦人科領域における術後血栓症予防に対するヘパリンの投与についての検討. 日本産科婦人科学会中国四国合同地方部会雑誌 1998;46:255-259
 
16) 神崎 徹:血栓症・塞栓症. 産科と婦人科 2000;67:357-362
 
P.205 掲載の参考文献
1) 藤井信吾:腹式単純子宮全摘術. 図説産婦人科VIEW 1, 単純子宮全摘術(藤井信吾, 桑原慶紀, 編). 1993;pp24-48, メジカルビュー社, 東京
 
2) 遠藤幸三:実地婦人科手術. 1970;pp129-169, 金原出版, 東京
 
3) 遠藤幸三:私の手術の要点と手技-単純性子宮全摘術の要点と手技. 産婦人科治療 1980;18:5-11
 
4) 高村郁世:実地に役立つ産婦人科手術の工夫とコツ-腹式単純全摘出術. 産婦人科治療 2000;80:115-126
 
5) 森 崇英, 小西郁生:腹式単純子宮全摘術-尿管損傷を避けるために. 産婦人科治療 1997;74 (増刊):583-591
 
6) 辻 啓:腟式単純子宮全摘術. 図説産婦人科VIEW1, 単純子宮全摘術(藤井信吾, 桑原慶紀, 編). 1993;pp78-95, メジカルビュー社, 東京
 
7) 工藤隆一, 寒河江悟, ほか:腟式手術の基本操作と実際. 産婦人科治療 1997;74(増刊):642-651
 
8) 岡村 均, 松浦講平, 水谷 洋:筋腫核出術. 図説産婦人科VIEW1, 単純子宮全摘術(藤井信吾, 桑原慶紀, 編). 1993;pp110-123, メジカルビュー社, 東京
 
9) 高橋 晃:子宮筋腫の手術. 産婦人科治療 1997;74(増刊):605-611
 
10) Mattingly RF:Myomata uteri. Te Linde's Operative Gynecology, 5th ed. 1977;pp187-222, Lippincott, Philadelphia
 
11) Buttram VC Jr, Reiter RC:Uterine leiomyomata. Surgical Treatment of the Infertile Female. 1985;pp201-228, Williams & Wilkins, Baltimore
 
P.217 掲載の参考文献
1) Vishnevskaya EE:Corpus uteri cancer:The results of surgical, combined and complex therapy. Eur J Gynecol Oncol 1991;12:139-145
 
2) Takeshima N, Numa H, et al:Treatment of stage III endometrial cancer:A case report of neoadjuvant chemotherapy followed by radical hysterectomy. J Jpn Soc Cancer Ther 1991;26:2544-2549
 
3) FIGO news:Corpus cancer staging. Int J Gynaecol Obstet 1989;28:190
 
4) 日本産科婦人科学会子宮癌委員会:全国子宮体癌調査成績, 第4報, 1989-1990年度症例. 1999
 
5) Boronow RC, Morrow CP, et al:Surgical staging in endometrial cancer. Clinical-pathotogic findings of a prospective study. Obstet Gynecol 1984;63:825-832
 
6) Yazigi R, Piver MS, Blumenson L:Malignant peritoneal cytology as prognostic indication in stage I endometrial cancer. Obstet Gynecol 1983;62:359-362
 
7) Hirai Y, Fujimoto I, et al:Peritoneal fluid cytology and prognosis in patients with endometrial carcinoma. Obstet Gynecol 1989;73:335-338
 
8) Zaino RJ, Kurman RJ, et al:Pathologic models to predict outcome for women with endometrial adenocarcinoma. Cancer 1996;77:1115-1121
 
9) 西谷雅史, 櫻木範明, ほか:予後を正確に反映した子宮体癌の進行期分類作成の試み. 産婦人科治療 1997;75:673-678
 
10) Takeshima N, Katase K, et al:Prognostic value of peritoneal cytology in patients with carcinoma of the uterine cervix. Gynecol Oncol 1997;64:136-140
 
11) Creasman WT, DiSaia PJ, et al:Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol 1981;141:921-929
 
12) Szpak CA, Creasman WT, et al:Prognostic value of cytologic examination of peritoneal washings in patients with endometrial carcinoma. Acta Cytol 1981;25:640-646
 
13) Keettel WC, Pixley EE, Buchsbaum HJ:Experience with peritoneal cytology in the management of gynecologic malignancies. Am J Obstet Gynecol 1974;120:174-182
 
14) Creasman WT, Rutledge F:The prognostic value of peritoneal cytology in gynecologic malignant disease. Am J Obstet Gynecol 1971;110:773-781
 
15) Mclellan R, Dillon MB, et al:Peritoneal cytology in endometrial cancer. A review. Obstet Gynecol Surv 1989;44:711-719
 
16) Imachi M, Tsukamoto N, et al:Peritoneal cytology in patients with endometrial carcinoma. Gynecol Oncol 1988;30:76-86
PubMed
17) Mazurka JL, Krepart GV, Lotocki RJ:Prognostic significance of positive peritoneal cytology in endometrial carcinoma. Am J Obstet Gynecol 1988;158:303-306
 
18) Turner DA, Gershenson DM, et al:The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet Gynecol 1989;74:775-780
 
19) Kashimura M, Sugihara K, et al:The significance of peritoneal cytology in uterine cervix and endometrial cancer. Gynecol Oncol 1997;67:285-290
 
20) Lurain JR, Rumsey NK, et al:Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of endometrium. Obstet Gynecol 1989;74:175-179
 
21) Grimshaw RN, Tupper WC, et al:Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol Oncol 1990;36:97-100
 
22) 加藤友康, 平井康夫, ほか:術中腹腔細胞診陽性の子宮体癌IIIa期における術後腹腔洗浄細胞診の検討. 日本産科婦人科学会雑誌 1995;47:643-646
 
23) Yanoh K, Takeshima N, et al:Morphologic analyses of positive peritoneal cytology in endometrial carcinoma. Acta Cytol 1999;43:814-819
 
24) Candiani GB, Belloni C, et al:Evaluation of different surgical approaches in the treatment of endometrial cancer at Figo stage I. Gynecol Oncol 1990;37:6-8
 
25) Gal D, Recio FO, et al:Lymphvascular space involvement-A prognostic indicator in endometrial adenocarcinoma. Gynecol Oncol 1991;42:142-145
 
26) Sakurai N, Tanaka T, et al:Extracorporeal spread and its prognostic impact in stages I and II (FIGO)endometrial carcinoma. Asia-Oceania J Obstet Gynaecol 1991;17:193-201
 
27) 竹島信宏, 梅沢 聡, ほか:子宮体癌骨盤内リンパ節転移に関する研究. 日本産科婦人科学会雑誌 1994;46:883-888
 
28) Girardi F, Petru E, et al:Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol 1993;49:177-180
 
29) Morrow CP, DiSaia PJ, Townsend DE:Current management of endometrial carcinoma. Obstet Gynecol 1973;42:399-406
 
30) Berman ML, Ballon SC, et al:Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol 1980;136:679-688
 
31) Creasman WT, Morrow CP. et al:Surgical pathologic spread patterns of endometrial cancer. Cancer 1987;60:2035-2041
 
32) Schink JC, Rademaker AW, et al:Tumor size in endometrial cancer. Cancer 1991;67:2791-2794
 
33) Takeshima N, Shimizu Y, et al:Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma. Gynecol Oncol 1994;54:321-326
 
34) Atsukawa S, Sasaki H, Tada S:A multivariate analysis of assessment of myometrial invasion of endometrial carcinoma by magnetic resonance imaging. Gynecol Oncol 1994;54:298-306
 
35) Doering DL, Barnhill DR, et al:Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma. Obstet Gynecol 1989;74:930-933
 
36) Takeshima N, Hirai Y, et al:Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion. Obstet Gynecol 1996;88:280-282
 
37) Kilgore LC, Partridge EE, et al:Adenocarcinoma endometrium. Survival comparison of patients with and without pelvic node sampling. Gynecol Oncol 1995;56:29-33
 
38) Morrow CP, Bundy BN, et al:Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium. Gynecol Oncol 1991;40:55-65
 
39) Homesley HD, Kadar N, et al:Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol 1992;167:1225-1230
PubMed
40) Moore DH, Fowler WC, et al:Morbidity of lymph node sampling in cancer of the uterine corpus and cervix. Obstet Gynecol 1989;74:180-184
 
41) Larson DM, Johnson K, Olson KA:Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer:Morbidity and mortality. Obstet Gynecol 1992;79:998-1001
 
42) Takeshima N, Hirai Y, Hasumi K:Prognostic validity of neoplastic cells with notable nuclear atypia in endometrial cancer. Obstet Gynecol 1998;92:119-123
 
43) 宇田康博, 中田さくら, ほか:わが教室における子宮体癌の取り扱い方. 産婦人科治療 1997;75:679-684
 
44) 竹島信宏, 梅沢 聡, ほか:子宮体癌筋層浸潤欠如症例に関する研究. 日本産科婦人科学会雑誌 1995;47:553-558
 
45) 今野 良, 佐藤信二, 矢嶋 聰:子宮体癌大動脈リンパ節郭清の意義, 適応, 術式, 予後, 多施設アンケート調査の解析. 産科と婦人科 1996;63:1197-1202
 
46) Homesley HD, Boronow RC, Lewis JL Jr:Treatment of adenocarcinoma of the endometrium at Memorial-James Ewing Hospitals, 1949-1965. Obstet Gynecol 1976;47:100-105
 
47) Burrell MO, Franklin EW III, Powell JL:Endometrial cancer:Evaluation of spread and follow-up one hundred eighty-nine patients with stage I or stage II disease. Am J Obstet Gynecol 1982;144:181-185
 
48) Mannel RS, Berman ML, et al:Management of endometrial cancer with suspected cervical involvement. Obstet Gynecol 1990;75:1016-1022
 
49) Takeshima N, Hirai Y, et al:Ovarian metastasis in endometrial cancer. Gynecol Oncol 1998;70:183-187
 
50) 竹島信宏, 梅沢聡, ほか:子宮体癌術後の再発に関する研究. 日本産科婦人科学会雑誌 1994;46:253-259
 
51) Grigsby PW, Perez CA, et al:Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium. Gynecol Oncol 1987;27:44-57
 
52) 田村博昭, 中井庸二, ほか:子宮体癌pT2症例に関する臨床的考察. 日本産科婦人科学会雑誌 1991;43:315-320
 
53) Yura Y, Tauchi K, et al:Parametrial involvement in endometrial carcinomas:Its incidence and correlation with other histological parameters. Gynecol Oncol 1996;63:114-119
 
54) 蔵本博行, 上坊敏子, ほか:子宮体癌に対するStaging Laparotomyの意義. 産科と婦人科 1995;62:1273-1281
 
55) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮体癌取扱い規約, 改訂第2版. 1996;pp15-17, 金原出版, 東京
 
P.232 掲載の参考文献
1) Curtin JP, Silverberg SG, et al:Corpus:Mesenchymal tumors. Principles and Practice of Gynecologic Oncology(Hoskins WJ, Perez CA, Young RC, eds), 2nd ed. 1997;pp897-918, Lippincott-Raven, Philadelphia
 
2) Echt G, Jepson J, et al:Treatment of uterine sarcomas. Cancer 1990;66:35-39
 
3) Wen BC, Tewfik FA, et al:Uterine sarcoma:A retrospectivc study. J Surg Oncol 1987;34:104-108
 
4) 竹内 聡, 丸尾 猛, ほか:婦人科腫瘍性病変の診断と治療効果判定-MRIと腫瘍マーカー併用の有用性について. 日本癌治療学会誌 1998;33:289
 
5) Peters WA 3d, Bagley CM, Smith MR:CA-125. Use as a tumor marker with mixed mesodermal tumors of the female genital tract. Cancer 1986;58:2625-2627
 
6) Nam JH, Chambers JT, et al:Urinary gonadotropin foragment, a new tumor marker. IV. Use in endometrial cancers and uterine mixed mullerian tumors. Gynecol Oncol 1990;39:352-357
 
7) Pattani SJ, Kier R, et al:MRI of uterine leiomyosarcoma. Magn Reson Imaging 1995;13:331-333
 
8) Worthington JL, Balfe DM, et al:Uterine neoplasms:MR imaging. Radiology 1986;159:725-730
 
9) Hata K, Hata T, et al:Uterine sarcoma:Can it be differentiated forom uterine leiomyoma with Doppler ultrasonography?A preliminary report. Ultrasound Obstet Gynecol 1997;9:101-104
 
10) Kurjak A, Predanic M, et al:Transvaginal color Doppler sonography in the assessment of pelvic tumor vascularity. Ultrasound Obstet Gynecol 1993;3:137-154
 
11) Hendrickson MR:Haris & Taylor Obstetrical and Gynaecological Pathology. 1995;pp519-586, Churchill Livingstone, New York
 
12) Shepherd JH:Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 1989;96:889-892
 
13) Olah KS, Dunn JA, Gee H:Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors:The result of a retrospective study of 423 cases of uterine sarcoma. Br J Obstet Gynaecol 1992;99:590-594
 
14) Major FJ, Blessing JA, et al:Prognostic factors in early-stage uterine sarcoma:A Gynecologic Oncology Group Study. Cancer 1993;71:1702-1709
 
15) 安田 允, 木村英三, ほか:腹式子宮全摘出術. 産婦人科治療 1989;58:621-627
 
P.244 掲載の参考文献
1) Berek JS(ed):Novak's Gynecology, 12th ed. 1996, Williams & Wilkins, Baltimore
 
2) 蜂須賀徹:妊娠合併卵巣腫瘍の管理. 新女性医学大系39, 産婦人科の良性腫瘍-子宮筋腫卵巣嚢腫, 乳房腫瘍(植木 實, 編). 1999;pp140-149, 中山書店, 東京
 
3) 筒井章夫:妊娠と卵巣腫瘍合併の取扱い方, その1 良性卵巣腫瘍. 日本産科婦人科学会雑誌 1992;44:N31-N34
 
4) 山辺 徹, 中島久良, 熊谷淳二:症例に於る良性卵巣腫瘍の取扱い-単純型嚢胞腫瘍. 産婦人科の実際 1983;31:1889-1894
 
5) 寺島芳輝, 落合和徳:卵巣腫瘍とその取り扱い方. 産婦人科治療 1994;68:274-278
 
6) 岡嶋祐子, 深澤一雄, 稲葉憲之:良性卵巣腫瘍の管理. 産婦人科治療 1994;68:279-285
 
7) DiSaia PJ, Creasman WT:The adnexal mass and early ovarian cancer. Clinical Gynecologic Oncology, 5th ed. 1997;pp253-281, Mosby-Year Book, St Louis
 
8) Golladay ES, Mollitt DL, Rock L:Ovarian masses in the child and adolescent. South Med J 1983;76:954-958
 
9) Van Winter JT, Simmons PS, Podratz KC:Surgically treated adnexal masses in infancy, childhood, and adolescence. Am J Obstet Gynecol 1994;170:1786-1789
 
10) Barber HRK, Graber EA:The PMPO syndrome(postmenopausal palpable ovarian syndrome). Obstet Gynecol 1971;38:921-930
 
11) Goldstein SR, Subramanyam B, et al:The postmenopausal cystic adnexal mass:The potential role of ultrasound in conservative management. Obstet Gynecol 1989;73:8-10
PubMed
12) Kroon E, Andolf E:Diagnosis and follow-up of simple ovarian cysts detected by ultrasound in postmenopausal women. Obstet Gynecol 1995;85:211-214
 
13) 東條伸平:卵巣の手術. アトラス婦人科手術書(川上 博, 西村敏雄, 編). 1977;pp124-135, 金原出版, 東京
 
14) 鈴木雅洲, 坂元正一, ほか(編):臨床産婦人科手術全書9. 1981, 金原出版, 東京
 
15) 落合和徳:手術のコツ-卵巣良性腫瘍. 日本産科婦人科学会雑誌 1990;42:N3-N6
 
16) 遠藤幸三:実地婦人科手術, 改訂第3版. 1992, 金原出版, 東京
 
17) Rose PG, Rubin RB, et al:Accuracy of forozen-section(intraoperative consultation)diagnosis of ovarian tumors. Am J Obstet Gynecol 1994;171:823-826
 
18) Puls L, Heidtman E, et al:The accuracy of forozen section by tumor weight for ovarian epithelial neoplasms. Gynecol Oncol 1997;67:16-19
 
19) Lim FK, Yeoh CL, et al:Pre and intraoperative diagnosis of ovarian tumours:How accurate are we?Aust N Z J Obstet Gynaecol 1997;37:223-227
 
20) Usubutun A, Altiok G, Kucukali T:The value of intraoperative consultation(forozen section) in the diagnosis of ovarian neoplasms. A cta Obstet Gynecol Scand 1998;77:1013-1016
 
21) Dottino PR, Levine DA, et al:Laparoscopic management of adnexal masses in premenopausal and postmenopausal women. Obstet Gynecol 1999;93:223-228
 
22) Michael CW, Lawrence WD, Bedrossian CW:Intraoperative consultation in ovarian lesions:A comparison between cytology and forozen section. Diagn Cytopathol 1996;15:387-394
 
23) Scucchi LF, Stefano DD, et al:Value of cytology as an adjunctive intraoperative diagnostic method. An audit of 2250 consecutive cases. Acta Cytol 1997;41:1489-1496
 
P.254 掲載の参考文献
1) 日本産科婦人科学会, 日本病理学会(編):卵巣腫瘍取扱い規約第1部. 1990;p21, 金原出版, 東京
 
2) 日本産科婦人科学会婦人科腫瘍委員会:全国卵巣悪性腫瘍調査成績第2報. 1992;p1, 日本産科婦人科学会, 東京
 
3) Nakashima N, Nagasaka T, et al:Ovarian epithelial tumors of borderline malignancy in Japan. Gynecol Oncol 1990;38:90-98
PubMed
4) Auranen A, Grenman S, et al:Borderline ovarian tumors in Finland:Epidemiology and familial occurrence. Am J Epidemiol 1996;144:548-553
 
5) Harris R, Whittemore AS, et al:Characteristics relating to ovarian cancer risk:Collaborative analysis of 12 US case-control studies. Am J Epidemiol 1992;136:1204-1211
 
6) Santesson L, Kottmeier H:General classification of ovarian tumours. UICC Monograph Series vol 11. 1968;pp1-8, Springer-Verlag, New York
 
7) Eltabbakh GH, Yadev PR, Morgan A:Clinical picture of women with early stage of ovarian cancer. Gynecol Oncol 1999;75:476-479
 
8) Link CJ, Reed E, et al:Borderline ovarian tumors. Am J Med 1996;101:217-225
 
9) Karen J, Trope CG, Aveler VM:A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital forom 1970 to 1982. Cancer 1993;71:1810-1820
 
10) 落合和徳, 篠崎英雄, ほか:上皮性卵巣腫瘍-境界悪性腫瘍の臨床的問題点. 日本婦人科病理・コルポスコピー学会雑誌 1997;15:156-163
 
11) Manchul LA, Simm J, et al:Borderline epithelial ovarian tumors:A review of 81 cases with an assessment of the impact of treatment Int J Rad Oncol Biol Phys 1992;22:867-874
 
12) Rice LW, Berkowitz RS, et al:Epithelial ovarian tumors of borderline malignancy. Gynecol Oncol 1990;39:195-198
 
13) Chambers JT, Merino MJ, et al:Borderline ovarian tumors. Am J Obstet Gynecol 1988;159:1088-1094
 
14) Bostwick DG, Tazelaar HD, et al:Ovarian epithelial tumors of borderline malignancy. Cancer 1986;58:2052-2065
 
15) Kliman L, Rome RM, Fortune DW:Low malignant potential tumors of the ovary:A study of 76 cases. Obstet Gynecol 1986;68:338-344
 
16) Barnhill D, Heller P, et al:Epithelial ovarian carcinoma of low malignant potential. Obstet Gynecol 1985;65:53-59
 
17) Tazelaar HD, Bostwick DG, et al:Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985;66:417-422
 
18) Nikrui N:Survey of clinical behavior of patients with borderline epithelial tumors of the ovary. Gynecol Oncol 1981;12:107-119
 
19) Eltabbakh GH, Natarajan N, et al:Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer. Gynecol Oncol 1999;74:103-107
 
20) Leake JF, Currie JL, et al:Long-term follow-up of serous ovarian tumors of low malignant potential. Gynecol Oncol 1992;47:150-158
 
21) Hart WR, Norris HJ:Borderline and malignant mucinous tumors of the ovary. Cancer 1973;31:1031-1045
 
22) Siriaunkgul S, Robbins KM, et al:Ovarian mucinous tumors of low malignant potential. Int J Gynecol Pathol 1995;14:198-208
 
23) Snider DD, Stuart GC, et al:Evaluation of surgical staging in stage I low malignant potential ovarian tumors. Gynecol Oncol 1991;40:129-132
 
24) Segal GH, Hart WR:Ovarian serous tumors of low malignant potential(serous borderline tumors). Am J Surg Pathol 1992;16:577-583
 
25) Nictolis M, Montironi R, et al:Serous borderline tumors of the ovary. Cancer 1992;70:152-160
 
26) Barnhill DR, Kurman RJ, et al:Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential, J Clin Oncol 1995;13:2752-2756
 
27) Kennedy AW, Hart WR:Ovarian papillary serous tumors of low malignant potential(serous borderline tumors). Cancer 1996;78:278-286
 
28) Gershenson DM, Silva EG:Serous ovarian tumors of low malignant potential with peritoneal implants, Cancer 1990;65:578-585
 
29) Cheng L, Wolf NG, et al:Peritoneal washing cytology of ovarian tumors of low malignant potential. Acta Cytol 1998;42:1091-1094
 
30) Sutton GP, Bundy BN, et al:Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Group study). Gynecol Oncol 1991;41:230-233
 
31) Leake JF, Rader JS, et al:Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1991;42:124-130
 
32) Bell DA, Scully RE:Clinicopathologic features of lymph node involvement with ovarian serous borderline tumors. Mod Pathol 1992;5:614
 
33) Shiraki M, Otis CN, et al:Ovarian serous borderline epithelial tumors with multiple retroperitoneal nodal involvement:Metastasis or malignant transformation of epithelial glandular inclusions? Gynecol Oncol 1992;46:255-258
PubMed
34) Tan LK, Flynn SD, Carcangiu ML:Ovarian serous borderline tumors with lymph node involvement. Am J Surg J Pathol 1994;18:904-912
 
35) Casey AC, Bell DA, et al:Epithelial ovarian tumors of borderline malignancy:Long-term follow-up. Gynecol Oncol 1993;50:316-322
 
36) Chien RTY, Rettenmaier MA, et al:Ovarian epithelial tumors of low malignant potential. Surg Gynecol Obstet 1989;169:143-146
 
37) FIGO:Annual report on the results of treatment in gynecological cancer. J Epidemiol Biostat 1998;3:79-101
 
38) Trimble CL, Trimble EL:Management of epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1994;55:S52-S61
 
39) 日本産科婦人科学会(編):卵巣腫瘍取扱い規約第2部. 1997:p18, 金原出版, 東京
 
40) Massad LS, Hunter VJ, et al:Epithelial ovarian tumors of low malignant potential. Obstet Gynecol 1991;78:1027-1032
 
41) Buy JN, Ghossain MA, et al:Epithelial tumors of the ovary:CT findings and correlation with US. Radiology 1991;178:811-818
 
42) Hata K, Hata T, et al:Ovarian tumors of low malignant potential:Transvaginal Doppler ultrasound features. Gynecol Oncol 1992;45:259-264
 
43) Rice LW, Lage JM, et al:Preoperative serum CA-125 levels in borderline tumors of the ovary. Gynecol Oncol 1992;46:226-229
 
44) Trope C, Karen J, et al:Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors. Gynecol Oncol 1993;51:236-243
 
45) Seidman JD, Kurman RJ:Subclassification of serous borderline tumors of the ovary into benign and malignant types. Am J Surg Pathol 1996;20:1331-1345
 
46) Lim-Tan SK, Cajigas HE, Scully RE:Ovarian cystectomy for serous borderline tumors:A follow-up study of 35 cases, Obstet Gynecol 1988;72:775-780
 
47) Bell DA, Weinstock MA, Scully RE:Peritoneal implants of ovarian serous borderline tumors. Cancer 1988;62:2212-2222
 
48) Prayson RA, Hart WR, Petras RE:Pseudomyxoma peritonei-A clinicopathologic study of 19 cases with emphasis on ste of origin and nature of associated ovarian tumors. Am J Surg Pathol 1994;18:591-603
 
49) Young RH, Gilks CB, Scully RE:Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei-A clinicopathologic analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol 1991;15:415-429
 
50) NIH Consensus Conference:Ovarian cancer-Screening, treatment, and follow-up. JAMA 1995;273:491-497
 
51) Guerrieri C, Hogberg T, et al:Mucinous borderline and malignant tumors of the ovary. Cancer 1994;74:2329-2340
 
P.269 掲載の参考文献
1) Buchsbaum HJ, Brady MF, et al:Surgical staging of carcinoma of the ovaries. Surg Gynecol Obstet 1989;169:226-232
 
2) Morrow CP, Curtin JP(eds):Surgery for ovarian neoplasia. Gynecologic Cancer Surgery. 1996;pp627-716, Churchill Livingstone, New York
 
3) Hoskins WJ, McGuire WP, et al:The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974-979
 
4) Hoskins WJ, Bundy BN, et al:The influence of cytoreductive surgery on recurrence-foree interval and survival in small-volume stage III epithelial ovarian cancer:A Gynecologic Oncology Group study. Gynecol Oncol 1992;47:159-166
 
5) van der Burg ME, van Lent M, et al:The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N Engl J Med 1995;332:629-634
 
P.270 掲載の参考文献
1) Messing MJ:Surgery for advanced ovarian cancer. Surgical Atlas of Gynecologic Oncology (Gallup DG, Talledo OE, eds). 1994;pp87-106, WB Saunders, Philadelphia
 
2) Heintz APM:Management of advanced ovarian cancer:Surgical aspects. Cancer in Women (Kavanagh JJ, Singletary SE, et al, eds). 1998;pp454-470, Blackwell Science, Malden
 
P.277 掲載の参考文献
1) Zanetta G, Chiari S, et al:Conservative surgery for Stage I ovarian carcinoma in women of childbearing age. Br J Obstet Gynaecol 1997;104:1030-1035
 
2) Young RC, Walton LA, et al:Adjuvant therapy in stage I and stage II epithelial ovarian cancer:Results of two prospective randomized trials. N Engl J Med 1990;322:1021-1027
 
3) Bertelsen K, Holund B, et al:Prognostic factors and adjuvant treatment in early epithelial ovarian cancer. Int J Gynecol Cancer 1993;3:211-218
 
4) Ahmed FY, Wiltshaw E, et al:Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol 1996;14:2968-2975
 
5) Sjovall K, Nilsson B, Einhorn N:Diforerent types of ruptured of the tumor capsule and the impact on survival in early ovarian carcinoma. Int J Gynecol Cancer 1994;4:333-336
 
6)Lentz SS, Cha SC, et al:Stage I ovarian epithelial carcinoma:Survival analysis following definitive treatment, Gynecol Oncol 1991;43:198-202
 
7) Rose PG, Rubin RB, et al:Accuracy of forozen-section (intraoperative consultation)diagnosis of ovarian tumors. Am J Obstet Gynecol 1994;171:823-826
 
8) Menzin AW, Rubin SC, et al:The accuracy of a forozen section diagnosis of borderline ovarian malignancy. Gynecol Oncol 1995;59:183-185
 
9) Weinstein D, Polishuk WZ:The role of wedge resection of the ovary as a cause for mechanical sterility. Surg Gynecol Obstet 1975;141:417-418
 
10) Eddy CA, Asch RH, Balmaceda JP:Pelvic adhesions following microsurgical and macrosurgical wedge resection of the ovaries. Fertil Steril 1980;33:557-561
 
11) Onda T, Yoshikawa H, et al:Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. Cancer 1996;78:803-808
 
12) Duffy DM, diZerega GS:Is peritoneal closure necessary?Obstet Gynecol Surv 1994;49:817-822
 
13) Franchi M, Ghezzi F, et al:Nonclosure of peritoneum at radical hysterectomy and pelvic node dissection:A randomized study. Obstet Gynecol 1997;90:622-627
 
14) Lalos O:Risk factors for tubal infertility among infertile and fertile women. Eur J Obstet Gynecol Reprod Biol 1988;29:129-136
 
15) Bahamondes L, Vera S, et al:Identification of main risk factors for tubal infertility. Fertil Steril 1994;61:478-482
 
16) Nordic Adhesion Prevention Study Group:The efficacy of Interceed for prevention of reformation of post-operative adhesions on ovaries, fallopian tubes, and fimbriae in microsurgical operations for fertility:A multicenter study. Fertil Steril 1995;63:709-714
 
17) Bines J, Oleske DM, Cobleigh MA:Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1996;14:1718-1729
 
18) 松本和紀, 川嶋正成, ほか:卵巣悪性腫瘍に対する妊孕性保存療法. 産婦人科の実際 1993;42:1245-1250
 
19) 金澤浩二:卵巣癌に対する機能温存治療後の妊孕能. Oncology & Chemotherapy 1998;14:305-310
 
20) Blumenfeld Z, Avivi I, et al:Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 1996;11:1620-1626
 
21) Berek JS:Epithelial ovarian cancer. Practical Gynecologic Oncology(Berek JS, Hacker HF, eds). 1994;pp338-339. Williams & Wilkins, Baltimore
 
P.287 掲載の参考文献
1) 日本産科婦人科学会(編):手術療法・治療法. 卵巣腫瘍取扱い規約第2部. 1992;pp20, 22, 金原出版, 東京
 
2) 西村治夫, 大蔵尚文, ほか:卵巣癌に対するsecond look operation(SLO)の評価-287例を対象として. 日本癌治療学会誌 1995;30:1721-1728
 
3) 高倉 聡, 落合和徳, ほか:卵巣癌根治術後のセカンドルック手術の意義. 日本産科婦人科学会雑誌 1998;50:111-118
 
4) Wangensteen OH, Lewis FJ, Tongen LA:The"second-look"in cancer surgery. Lancet 1951;71:303-307
 
5) Santoro BT, Griffen WO, Jr, Wangensteen OH:The second look procedure in the management of ovarian malignancies and pseudomyxoma peritonei. Surgery 1961;50:354-358
 
6) Smith JP, Delgado G, Rutledge F:Second-look operation in ovarian carcinoma. Cancer 1976;38:1438-1442
 
7) 薬師寺道明, 西村治夫:SLO(second look operation)の意義と問題点-卵巣癌患者を対象として. 日本産科婦人科学会雑誌 1996;48:761-768
 
8) Friedman RL, Eisenkop SM, Wang H-J:Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival. Gynecol Oncol 1997;67:88-94
 
9) Gershenson DM, Copeland LJ, et al:Prognosis of surgically determined complete responders in advanced ovarian cancer. Cancer 1985;55:1129-1135
 
10) Rubin SC, Hoskins WJ, et al:Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecol Oncol 1991;42:137-141
 
11) Copeland LJ, Gershenson DM, et al:Microscopic disease at second-look laparotomy in advanced ovarian cancer. Cancer 1985;55:472-478
 
12) Creasman WT, Galls S, et al:Second-look laparotomy in the patients with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group study). Gynecol Oncol 1989;35:378-382
 
13) 牛嶋公生, 杉山 徹, ほか:上皮性卵巣癌に対するsecond-look operation(SLO)の意義と問題点. 日本産科婦人科学会雑誌 1999;51:119-126
 
14) Podratz KC, Malkasian GD, et al:Second-look laparotomy in ovarian cancer:Evaluation of pathologic variables. Am J Obstet Gynecol 1985;152:230-238
 
15) Cain JM, Saigo PE, et al:A review of second-look laparotomy for ovarian cancer. Gynecol Oncol 1986;23:14-25
 
16) Carmichael JA, Shelley WE, et al:A predictive index of cure versus no cure in advanced ovarian carcinoma patients-replacement of second-look laparotomy as a diagnostic test. Gynecol Oncol 1987;27:269-278
 
17) Podratz KC, Malkasian GD, et al:Recurrent disease after negative second-look laparotomy in stage III and IV ovarian carcinoma. Gynecol Oncol 1988;29:274-282
 
18) Ghatage P, Krepart GV, et al:Factor analysis of false-negative second-look laparotomy. Gynecol Oncol 1990;36:172-175
 
19) Potter ME, Hatch KD, et al:Second-look laparotomy and salvage therapy:A research modality only? Gynecol Oncol 1992;44:3-9
 
20) Wiltshaw E, Raju KS, Dawson I:The role of cytoreductive surgery in advanced carcinoma of the ovary:An analysis of primary and second surgery. Br J Obstet Gynaecol 1985;92:522-527
 
21) Luesley D, Lawton F, et al:Failure of second-look laparotomy to influence survival in epithelial ovarian cancer., Lancet 1988;ii:599-603
 
22) Friedman JB, Weiss NS:Second thoughts about second-look laparotomy in advanced ovarian cancer. N Eng J Med 1990;322:1079-1082
 
23) Schneider J, Centeno MM, et al:Negative second-look laparotomy does not preclude recurrence in stage I ovarian carcinoma of any histological variety. Eur J Gynaecol Oncol 1993;14:36-3
PubMed
24) Nicoletto MO, Tumolo S, et al:Surgical second look in ovarian cancer:A randomized study in patients with laparoscopic complete remission-A Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group study. J Clin Oncol 1997;15:994-999
 
25) Williams L, Brunetto VL, et al:Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer:A Gynecologic Oncology Group study. Gynecol Oncol 1997;66:171-178
 
26) Hoskins WJ, Bundy BN, et al:The influence of cytoreductive surgery on recurrent-foree interval and survival in small-volume stage III epithelial ovarian cancer:A Gynecologic Oncology Group study. Gynecol Oncol 1992;47:159-166
 
27) Rubin SC, Jones WB, et al:Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging. Obstet Gynecol 1993;82:139-142
 
28) Qu JY, Sun AD, et al:Laparoscopy in the diagnosis and management of ovarian cancer. J Reprod Med 1984;29:483-488
 
29) Ozols RT, Fisher RI, et al:Peritoneoscopy in the management of ovarian cancer. Am J Obstet Gynecol 1981;140:611-619
 
30) Shinozuka T, Miyamoto T, et al:Follow-up laparoscopy in patients with ovarian cancer. Tokai Exp Clin Med 1994;19:53-59
 
31) Gadducci A, Sartori E, et al:Analysis of failure after negative second-look in patients with advanced ovarian cancer:An Italian multicenter study. Gynecol Oncol 1998;68:150-155
 
32) Abu-Rustum NR, Barakat RR, et al:Second-look operation for epithelial ovarian cancer:Laparoscopy or laparotomy?Obstet Gynecol 1996;88:549-553
 
33) Clough KB, Ladonne JM, et al:Second look for ovarian cancer:Laparoscopy or laparotomy? A prospective comparative study. Gynecol Oncol 1999;72:411-417
PubMed
34) NIH Consensus Conference:Ovarian cancer. Screening, treatment, and follow-up. JAMA, 1995;273:491-497
 
35) Berek JS:Surgery for ovarian cancer. Educational Book, Thirty-once Annual Meeting of ASCO. 1995;pp356-357 American Society of Clinical Oncology
 
P.294 掲載の参考文献
1) 恒松隆一郎:治療の概要(ストラテジー). 新女性医学大系36, 卵巣・卵管の悪性腫瘍(薬師寺道明, 編). 1999;pp215-230, 中山書店, 東京
 
2) 葛谷和夫:cytoreductive surgery, 合併手術. 新女性医学大系36, 卵巣・卵管の悪性腫瘍(薬師寺道明, 編). 1999;pp240-249, 中山書店, 東京
 
3) 落合和徳:second look laparotomy. 新女性医学大系36, 卵巣・卵管の悪性腫瘍(薬師寺道明, 編). 1999;pp250-260, 中山書店, 東京
 
4) Munnel EW:The changing prognosis and treatment in cancer of the ovary. A report of 235 patients with primary ovarian carcinoma 1952-1961. Am J Obstet Gynecol 1968;100:790-805
 
5) Griffiths CT:Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma Natl Cancer Inst Monogr 1975;42:101-104
 
6) Heintz APM:Secondary cytoreductive surgery:Who benefits forom it? Gynecol Oncol 1997;66:169-170
 
7) Griffths CT:Management of Ovarian Cancer. 1986;pp60-72, Butterworths, London
 
8) Berek JS, Trope C, Vergote I:Surgery during chemotherapy and at relapse ofovarian cancer. Ann Oncol 1999;10(suppl):3-7
 
9) van der Burg ME, van Lent M, et al:The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 1995;332:629-634
 
10) Carson LF, Rubin SC:Secondary cytoreduction-Thoughts on the "Pro" side. Gynecol Oncol 1993;51:127-130
 
11) Podcaski E, Manetta A, et al:Survival of patients with ovarian epithelial carcinomas after second-look laparotomy. Gynecol Oncol 1990;36:43-47
 
12) Luesley DM, Chan KK, et al:Survival after negative second-look laparotomy, Eur J Surg Oncol 1989;15:205-210
 
13) Chambers SK, Chambers JT, et al:Evaluation of the rule of second-look surgery in ovarian cancer. Obstet Gynecol 1988;72:404-408
 
14) Podratz K, Schray M, et al:Evaluation of treatment and survival after positive second-look laparotomy. Gynecol Oncol 1988;31:9-21
PubMed
15) Hoskins W, Rubin SC, et al:Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma. Gynecol Oncol 1989;34:365-371
 
16) Creasman WT, Gall S, et al:Second-look laparotomy in the patient with minimal residual stage III ovarian cancer(a Gynecologic Oncology Group study). Gynecol Oncol 1989;35:378-382
 
17) Smirz L, Stehman F, et al:Second-look laparotomy after chemotherapy in the management of ovarian malignancy. Am J Obstet Gynecol 1985;152:661-668
 
18) Lippman S, Alberts D, et al:Second-look laparotomy in the epithelial ovarian carcinoma. Cancer 1988;61:2571-2577
 
19) Williams L, Brunetto VL, et al:Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer:A Gynecologic Oncology Group study. Gynecol Oncol 1997;66:171-178
 
20) Krag KJ, Canellos GP, et al:Predictive factors for long-term survival in patients with advanced ovarian cancer. Gynecol Oncol 1989;34:88-93
 
21) Potter ME:Secondary cytoreduction in ovarian cancer:Pro or con?Gynecol Oncol 1993;51:131-135
PubMed
22) Sharp F, Blackett AD, et al:Conclusion and recommendation forom the Helene Harris Memorial Trust Fifth Biennial International Forum in ovarian cancer. Int J Gynecol Cancer 1995;5:449-458
 
23) Eisenkop SM, Friedman RL, Spirtos NM:The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer 2000;88:144-153
 
24) Cormio G, di Vagno G, et al:Surgical treatment of recurrent ovarian cancer:Report of 21 cases and a review of the literature. Eur J Obstet Gynecol Reprod, Biol 1999;86:185:188
 
25) Gemignani ML, Chi DS, et al:Splenectomy in recurrent epithelial ovarian cancer. Gynecol Oncol 1999;72:407-410
 
26) Kawana K, Yoshikawa H, et al:Successful treatment of brain metastases forom ovarian cancer using gamma-knife radiosurgery. Gynecol Oncol 1997;65:357-359
 
27) Suzuki M, Tsukagoshi S, et al:A patient with brain metastasis forom ovarian cancer who showed complete remission after multidisciplinary treatment. Gynecol Oncol 1999;74:483-486
 
28) Lawton FG, Redman CW, et al:Neoadjuvant(cytoreductive)chemotherapy combined with intervention debulking surgery in advanced unresected epithelial ovarian cancer. Obstet Gynecol 1989;73:61-65
 
29) Jacob JH, Greshenson DM, et al:Neoadjuvant chemotherapy and interval debulking surgery for advanced ovarian cancer. Gynecol Oncol 1991;42:146-150
 
30) Schwarz PE, Cambers JT, Makuch R:Neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol 1994;53:33-37
 
31) Surwit E, Chiders J, et al:Neoadjuvant chemotherapy for advanced ovarian cancer. Int J Gynecol Cancer 1996;6:356-361.
 
32) Vergote I, De Wever I, et al:Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma:A retrospective analysis of 285 patients Gynecol Oncol 1998;71:431-436.
 
P.301 掲載の参考文献
1) Schiller W:Concepts of a new classification of ovarian tumors. Surg Gynecol Obstet 1940;70:773-782
 
2) Serov SF, Scully RE, Sobin LH:Histological Typing of Ovarian Tumours. 1973, World Health Organization, Geneva
 
3) Nishida T, Sugiyama T, et al:Histologic characterization of rat ovarian carcinoma induced by intraovarian insertion of 7, 12-dimethylbenz[a]anthracene-coated suture:Common epithelial tumors of the ovary in rats? Cancer 1998;83:965-970
 
4) Hoskins WJ:Surgical staging and cytoreductive surgery of epithelial ovarian cancer. Cancer 1993;71:1534-1540
 
5) Monfardini S, Brunner K, et al(eds):Manual of Cancer Chemotherapy(UICC Technical Report Series, vol 56). 1981;p35, 11b, p17, International Union Against Cancer, Geneva
 
6) Gershenson DM, Malone JM Jr:Chemotherapy for malignant germ cell tumors of the ovary. Chemotherapy of Gynecologic Cancer(Deppe G, ed), 2nd ed. 1990;pp217-239, Wiley-Liss, New York
 
7) Smith JP, Rutledge FN:Advances in chemotherapy for gynecologic cancer. Cancer 1975;36:669-674
 
8) Einhorn LH, Donohue J:Cis-diamminedichloroplatinum, vinblastine, and bleomycin in dis-seminated testicular cancer. Ann In tern Med 1977;87:293-298
 
9) Williams SD, Birch R, et al:Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987;316:1436-1440
PubMed
10) 西田 敬, 西田富英, ほか:卵巣充実性奇形腫の臨床・病理学的検討. 日本産科婦人科学会雑誌 1983;35:259-265
 
11) 西田 敬, 加藤 俊, 薬師寺道明:卵巣embryonal carcinoma(樋口・加藤)の臨床的検討. 日本産科婦人科学会雑誌 1984;36:415-420
 
12) 片岡明生, 薬師寺道明, ほか:卵巣胚細胞性悪性腫瘍の臨床病理学的検討. 日本産科婦人科学会雑誌 1989;41:695-701
 
13) 西田 敬, 嘉村敏治:胚細胞腫瘍の化学療法の現況. Oncology & Chemotherapy 1999;15:231-239
 
14) Kottmeier HL:Presentation of therapeutic results in carcinoma of the female pelvis. Experience of the annual report on the results of treatment in carcinoma of the uterus, vagina and ovary. Gynecol Oncol 1976;4:13-19
 
15) Norris HJ, O'Connor DM:Pathology of malignant germ cell tumors of ovary. Gynecologic Oncology (Coppleson M, ed), 2nd ed, vol 2. 1992;pp917-934, Churchill livingstone, London
 
16) Gershenson DM:The obsolescence of second-look laparotomy in the management of malignant ovarian germ cell tumors. Gynecol Oncol 1994;52:283-285
 
17) Mandanas RA, Saez RA, et al:Long-term results of autologous marrow transplantation for relapsed or reforactory male or female germ cell tumors. Bone Marrow Transplant 1998;21:569-576
 
P.309 掲載の参考文献
1) Pettersson F:Staging rules for gestational trophoblastic tumor and fallopian tube cancer. Acta Obstet Gynecol Scand 1992;71:224-225
 
2) Southwood WFW:Carcinoma of the uterine tube:A review and a description of a case with unusual clinical features, presenting as an acute abdominal emergency. Br J Surg 1956;44:487-492
 
3) Deppe G, Malone M Jr, Lawrence W:Cancer of the fallopian tube. Female Genital Cancer (Gusberg S, Shingleton H, Deppe G, eds). 1988;pp427-434, Churchill livingstone, New York
 
4) Stock RJ:The fallopian tube. Clinical Gynecologic Pathology(Hernandez E, Atkinson B, eds). 1996;pp361-402, WB Saunders, Philadelphia
 
5) Silverberg SG:The fallopian tube. Pathology in Gynecologic and Obstetrics(Gompel C, Silverberg SG, eds), 4th ed. 1994;pp284-312, JB Lippincott, Philadelphia
 
6) Peters WAM, Anderson WA, et al:Prognostic features of carcinoma of the fallopian tube. Obstet Gynecol 1988;71:757-762
 
7) Yeung HHY, Bannatyne P, Russel P:Adenocarcinoma of the fallopian tubes:A clin copathological study of eight cases. Pathology 1983;15:279-286
 
8) Hu CY, Taymor ML, Hertig AT:Primary carcinoma of the fallopian tube., Am J Obstet Gynecol 1950;59:58-67
 
9) Bannatyne P, Russell P:Early adenocarcinoma of the fallopian tubes:Acase for muhifocal tumorigenesis. Diagn Gynecol Obstet 1981;3:49-60
 
10) Asmussen M, Kaern J, et al:Primary adenocarcinoma localized to the fallopian tubes:Report on 33 cases. Gynecol Oncol 1988;30:183-186
 
11) Schink JC, Lurain JR:Rare gynecologic malignancies. Curr Opin Obstet Gynecol 1991;3:78-90
 
12) Woolas R, Jacobs I, et al:What is the true incidence of primary fallopian tube carcinoma? Int J Gynecol Cancer 1994;4:384-388
 
13) Henderson SR, Harper RC, et al:Primary carcinoma of the fallopian tube:Difficulties in diagnosis and treatment. Gynecol Oncol 1977;5:168-179
 
14) Hirai Y, Kaku S, et al:Clinical study of primary carcinoma of the fallopian tube:Experience with 15 cases. Gynecol Oncol 1989;34:20-26
 
15) Sedlis A:Carcinoma of the fallopian tube, Surg Clin North Am 1978;58:121-129
 
16) Barakat RR, Rubin SC, et al:Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol 1991;42:156-160
 
17) Barakat RR, Rubin SC, et al:Second look laparotomy in carcinoma of the fallopian tube. Obstet Gynecol 1993;82:748-751
 
18) Morris M, Gershenson DM, et al:Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 1990;76:1020-1024
 
19) Benedet JL, White GW, et al:Adenocarcinoma of the fallopian tube:Experience with 41 patients. Obstet Gynecol 1977;50:654-657
 
20) Frigerio L, Pirondini A, et al:Primary carcinoma of the fallopian tube. Tumori 1993;79:40-44
 
21) Markman M, Zaino RJ, et al:Carcinoma of the fallopian tube. Principles and Practice of Gynecologic Oncology(Hoskins WJ, Perez CA, Young RC, eds), 2nd ed. 1997;pp1025-1038, Lippincott-Raven, Philadelphia
 
22) Roberts JA, Lifshitz S:Primary adenocarcinoma of the fallopian tube. Gynecol Oncol 1982;13:301-308
 
23) Schray MF, Podratz KC, Malkasian GD:Fallopian tube cancer:The role of radiation therapy. Radiotion Oncol 1987;10:267-275
 
24) Wheeler JE:Diseases of the fallopian tube. Blaustein's Pathology of the Female Genital Tract (Kurmann RJ, ed), 4th ed. 1994;pp529-562, Springer-Verlag, New York
 
25) King A, Seraj IM, et al:Fallopian tube carcinoma:A clinicopathological study of 17 cases. Gynecol Oncol 1989;33:351-355
 
26) Jones OV:Primary carcinoma of the uterine tube. Obstet Gynecol 1965;26:122-129
 
27) Tokunaga T, Miyazaki K, et al:Serial measurement of CA 125 in patients with primary carcinoma of the fallopian tube. Gynecol Oncol 1990;36:335-337
 
28) Puls LE, Davey DD, et al:Immunohistochemical staining for CA-125 in fallopian tube carcinomas. Gynecol Oncol 1993;48:360-363
 
29) Baekelandt M, Kockx M, et al:Primary adenocarcinoma of the fallopian tube. Review of the literature. Int J Gynecol Cancer 1993;3:65-71
 
30) Van Nagell J, Higgins R, et al:Transvaginal sonography as a screening method for ovarian cancer. Cancer 1990;65:573-577
 
31) Campbell S, Royston P, et al:Novel screening strategies for early ovarian cancer by transabdominal ultrasonography. Br J Obstet Gynaecol 1990;97:304-311
 
32) Sedlis A:Primary carcinoma of the fallopian tube. Obstet Gynecol Surv 1961;16:209-226
 
33) Kubler HC, Kuhn W, et al:Diagnosis of occult fallopian tube cancers by intraoperative peritoneal cytology. Geburtshilfe Frauenheilkd 1988;48:116-118
 
34) Benson P:Psammoma bodies found in cervicovaginal smears. Acta Gynecol 1973;17:64-66
 
35) Berg JW, Lampe JG:High-risk factors in gynecologic cancer. Cancer 1981;48:429-441
 
36) Erez S, Kaplan A, Wall J:Clinical staging of carcinoma of the uterine tube. Obstet Gynecol 1967;30:547-550
 
37) 中井庸二, 中山貴弘, ほか:原発性卵管癌-その臨床像と進行期分類の問題点についての検討. 日本産科婦人科学会雑誌 1988;40:1499-1505
 
38) Pfiffer P, Mongensen H, et al:Primary carcinoma of the fallopian tube. Acta Oncol 1989;28:7-11
 
39) Kinzel G:Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1976;125:816-820
 
40) Yoonessi M:Carcinoma of the fallopian tube. Obstet Gynecol Surv 1979;34:257-270
 
41) Schiller HM, Silverberg SG:Staging and prognosis in primary carcinoma of the fallopian tube. Cancer 1971;28:389-395
 
42) Plentl AA, Friedman EA:Lymphatics of the fallopian tube. Lymphatic System of the Female Genitalia:The Morphologic Basis of Oncologic Diagnosis and Therapy (Plentl AA, Friedman EA, eds). 1971;pp153-167, WB Saunders, Philadelphia
 
43) Momtazee S, Kempson RL:Primary adenocarcinoma ofthe fallopian tube. Obstet Gynecol 1968;32:649-656
 
44) Sampson J:The lymphatics of the mucosa of the fimbriae of the fallopian tube. Am J Obstet Gynecol 1937;33:325-329
 
45) Tamimi HK, Figge DC:Adenocarcinoma of the uterine tube:Potential for lymph node metastasis. Am J Obstet Gynecol 1981;141:132-137
 
46) Semrad N, Watring W, et al:Fallopian tube adenocarcinoma:Common extraperitoneal recurrence. Gynecol Oncol 1986;24:230-235
 
47) Eddy G, Copeland L, et al:Fallopian tube carcinoma. Obstet Gynecol 1984;64:546-552
 
48) Cormio G, Maneo A, Gabriele A:Primary carcinoma of the fallopian tube. A retrospective analysis of 47 patients. Ann Oncol 1996;7:271-275
 
49) Klein M, Rosen A, Lahousen M:Lymphogenous metastasis in the primary carcinoma of the fallopian tube. Gynecol Oncol 1994;55:336-338
 
50) Rosen A, Klein M, et al:Primary carcinoma ofthe fallopian tube. A retrospective analysis of 115 patients. Br J Cancer 1995;68:605-609
 
51) Munts H, Tarraza H, et al:Primary adenocarcinoma of the fallopian tube. Eur J Gynaecol Oncol 1989;10:239-249
 
52) Rose PG. Piver MS. Tsukada Y:Fallopian tube cancer. The Roswell Park experience. Cancer 1990;66:2661-2667
 
53) Brown MD, Kohorn EI, et al:Fallopian tube carcinoma. Int J Radiat Oncol Biol Phys 1985;11:583-590
 
54) Podratz KC, Podczaski ES, et al:Primary carcinoma ofthe fallopian tube. Am J Obstet Gynecol 1986;154:1319-1326
 
55) Pectasides D, Barbounis V, et al:Treatment of primary fallopian tube carcinoma with cisplatin containing chemotherapy. Am J Clin Oncol 1994;17:68-71
 
56) Raju K, Barker G, Wiltshaw E:Primary carcinoma of the fallopian tube. Report of 22 cases. Br J Obstet Gynaecol 1981;88:1124-1129
 
57) McMurray EH, Jacobs AJ, et al:Carcinoma of the fallopian tube:Management and sites of failure. Cancer 1986;58:2070-2075
 
58) Deppe G, Bruckner HW, Cohen CJ:Combination chemotherapy for advanced carcinoma of the fallopian tube. Obstet Gynecol 1980;56:530-532
 
59) Guthrie D, Cohen S:Carcinoma ofthe fallopian tube treated with a combination of surgery and cytotoxic chemotherapy. Case report. Br J Obstet Gynaecol 1981;88:1051-1053
 
60) Jacobs AJ, McMurray EH, et al:Treatment of carcinoma of the fallopian tube using cisplatin, doxorubicin, and cyclophosphamide. Am J Clin Oncol 1986;9:436-439
 
61) Johnston GA:Primary malignancy of the fallopian tube:A clinical review of 13 cases. J Surg Oncol 1983;24:304-309
 
62) Maxon WZ, Stehman FB, et al:Primary carcinoma of the fallopian tube:Evidence for activity of cisplatin combination therapy. Gynecol Oncol 1987;26:305-313
 
63) Peters WA, Anderson WA, Hopkins MP:Results of chemotherapy in advanced carcinoma of the fallopian tube. Cancer 1989;63:836-838
 
64) Young JA, Kossman CR, Green MR:Adenocarcinoma of the fallopian tube:Report of a case with an unusual pattern of metastasis and response to combination chemotherapy. Gynecol Oncol 1984;17:238-240
 
65) Jacobs A, Kao MS, et al:Treatment and prognosis of fallopian tube carcinoma. Gynecol Oncol 1985;20:247-251
 
66) Rubin SC, Hoskins WJ, et al:Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy. Gynecol Oncol 1991;42:137-141
 
67) Eddy GL, Copeland LJ, Gershenson DM:Second-look laparotomy in fallopian tube carcinoma. Gynecol Oncol 1984;19:182-186
 
68) Harrison CR, Averette HE, et al:Carcinoma of the fallopian tube:Clinical management. Gynecol Oncol 1989;32:357-359
 
69) Roberts JA, Lifshitz S:Primary adenocarcinoma ofthe fallopian tube. Gynecol Oncol 1982;13:301-308
 
70) 清水敬生, 石谷敬之, ほか:卵巣癌に対するcomprehensive surgery-傍大動脈リンパ節郭清を中心に. 産婦人科手術 1997;8:99-108
 
P.319 掲載の参考文献
1) 日本母性保護産婦人科医会:日母研修ノートNo 57, 流産・早産の管理. 1997;pp25-30, 日本母性保護産婦人科医会, 東京
 
2) 日本母性保護産婦人科医会:会員必携No 1, 指定医師必携. 1998;pp23-33, 日本母性保護産婦人科医会, 東京
 
3) Curry SL, Hammond CB, et al:Hydatidiform mole:Diagnosis, management and long-term follow up of 347 patients. Obstet Gynecol 1975;45:1-8
 
4) Bagshawe KD:Choriocarcinoma. The Clinical Biology of the Trophoblast and Its Tumours. 1969;p39, Edward Arnold, London
 
5) Ratnam SS, Chew H:Surgery for metastatic trophoblastic tumours. Abstracts forom International symposium:Gestational Trophoblastic Tumors. 1979;p28, London
 
6) Kanazawa K, Sasagawa M, et al:Clinical evaluation of focal excision of myometrial lesion for treatment of invasive hydatidiform mole. Acta Obstet Gynecol Scand 1988;67:487-492
 
7) Wilson RB, Beecham CT, Symmonds RE:Conservative surgical management ofchorioadenoma destruens. Obstet Gynecol 1965;26:814-820
 
8) 半藤 保, 大野正文, ほか:子宮筋腫核出術における出血. 量軽減対策. 産婦人科の実際 1997;46:1701-1705
 
9) Clayton LA, Barnard DE, et al:The role of surgery in the management of gestational trophoblastic disease. Semin Oncol 1982;9:213-220
 
10) Bagshawe KD:Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:1373-1385
 
11) Hammond CB, Weed JC, Currie JL:The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol 1980;136:844-858
 
12) Ratnam SS, Ilancheran A:Disease of the trophoblast. Clin Obstet Gynecol 1982;9:539-564
 
13) Hertz R:Choriocarcinoma and Related Gestational Trophoblastic Tumours in Women. 1978;pp1-170, Raven Press, New York
 
14) 岡本知光, 野村誠二, 水谷栄彦:難治性絨毛癌の治療. 産科と婦人科 1999;66(増刊):248-252
 
15) Lewis JL Jr:Current status of treatment of gestational trophoblastic disease. Cancer 1976;38:620-626
 
16) Bagshawe KD, Harland S:Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous system. Cancer 1976;38:112-118
 
17) Weed JC, Hammond CB:Cerebral metastatic choriocarcinoma:Intensive therapy and prognosis. Obstet Gynecol 1980;55:89-94
 
18) WHO:WHO Technical Report Series 692, Gestational Trophoblastic Disease. 1983, WHO, Geneva
 
19) Hammond CB, Borchert LG, et al:Treatment of metastatic trophoblastic disease:Good and poor prognosis. Am J Obstet Gynecol 1973;115:451-457
 
20) Bagshawe KD, Garnett ES:Radiological changes in the lungs of patients with trophoblastic tumours. Br J Radiol 1963;36:673-679
 
21) 友田 豊, 後藤節子:絨毛性疾患の診断と治療. 1996;p141, 永井書店, 大阪
 
22) Lacey CG, Barnard D, et al:Irradiation of liver metastases due to gestational choriocarcinoma. Obstet Gynecol 1983;61:715-755
 
23) Surwit EA, Alberts DS, Christian CD:Poor prognosis gestational trophoblastic disease-An update. Obstet Gynecol 1984;64:21-28
 
24) Wong LC, Choo YC, Ma HK:Hepatic metastases in gestational trophoblastic disease. Obstet Gynecol 1986;67:107-111
 
25) Lewis J Jr, Gore H, et al:Treatment of trophoblastic disease. With rationale for the use of adjunctive chemotherapy at the time of indicated operation. Am J Obstet Gynecol 1966;96:710-722
 
26) Lewis J Jr, Ketcham AS, Hertz R:Surgical intervention during chemotherapy of gestational trophoblastic neoplasms. Cancer 1966;19:1517-1522
 
27) Green-Thompson RW:Surgery in the management of gestational trophoblastic disease. Bainieres Clin Obstet Gynaecol 1987;1:293-317
 
P.327 掲載の参考文献
1) Nelson JH:Pretreatment staging. Cancer 1981;48:543-547
 
2) Creasman WT, Boronow RC, Morrow CP:Adenocarcinoma of the endometrium:Its metastatic lymph node potential. Gynecol Oncol 1976;4:239-243
 
3) 塚本直樹, 松隈敬太, ほか:傍大動脈リンパ節の生検法. 産婦人科治療 1988;56:101-107
 
4) The Oncology Committee of the International Federation of Gynecology and Obstetrics. FIGO news:Changes to the 1985 FIGO report on the result of treatment in gynecological cancer. Int J Gynaecol Obstet 1987;25:87-88
 
5) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮体癌取扱い規約, 第2版. 1996, 金原出版, 東京
 
6) Burghardt E, Girardi F, et al:Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 1991;40:103-106
 
7) 日本産科婦人科学会(編):卵巣腫瘍取扱い規約第2部, 第1版. 1992, 金原出版, 東京
 
8) 日本産科婦人科学会, 日本病理学会, 日本医学放射線学会(編):子宮頸癌取扱い規約, 第2版. 1997, 金原出版, 東京
 
9) Belinson JL, Goldberg MI, Averette HE:Paraaortic lymphadenectomy in gynecologic cancer. Gynecol Oncol 1979;7:188-198
 
10) Donohue JP:Retroperitoneal lymphadenectomy:The anterior approach including bilateral suprarenal-hilar dissection. Urol Clin North Am 1977;4:509-521
 
11) Berman ML, Lagasse LD, et al:The operative evaluation of patients with cervical carcinoma by an extraperitoneal approach. Obstet Gynecol 1977;50:658-664
 
12) Schellhas HF:Extraperitoneal paraaortic node dissection through an upper abdominal incision. Obstet Gynecol 1975;46:444-447
 
13) Querleu D, LeBlanc E:Laparoscopic infrarenal paraaortic lymph node dissection for restaging of carcinoma of the ovary or fallopian tube. Cancer 1994;73:1467-1471
PubMed
14) 塚本直樹, 嘉村敏治, ほか:悪性腫瘍の転移-傍大動脈リンパ節転移と婦人科悪性腫瘍. 産科と婦人科 1991;58:939-944
 
15) 斉藤俊章, 塚本直樹, ほか:子宮体癌, 卵巣癌のリンパ節転移と予後. 産婦人科の世界 1993;45:199-204
 
16) Tsuruchi N, Kamura T, et al:Relationship between paraaortic lymph node involvement and intraperitoneal spread in patients with ovarian cancer-A multivariate analysis. Gynecol Oncol 1993;49:51-55
 
17) Onda T, Yoshikawa H, et al:Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy., Br J Cancer 1997;78:1836-1841
 
18) Onda T, Yoshikawa H, et al:Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to stage I/II patients and superior survival to other stage III. Cancer 1998;83:1555-1560
 
19) 松隈敬太, 塚本直樹, ほか:婦人科悪性腫瘍の前斜角筋リンパ節転移の検討. 癌の臨床 1989;35:275-279
 
P.342 掲載の参考文献
1) 塚本直樹:最近の外陰癌の手術療法. Oncology & Chemotherapy 1997;13:207-212
 
2) Morrow CP, Curtin JP:Gynecologic Cancer Surgery. 1996;pp323-380, Churchill Livingstone, New York
 
3) McCraw JB, Massey FM, et al:Vaginal reconstruction with gracilis myocutaneous flaps. Plast Reconstr Surg 1976;58:176:183
 
4) 塚本直樹:Gracilis myocutaneous flapによる外陰・腟の再建術. 産婦人科治療 1989;58:5-10
 
5) 宇田M晃一, 一瀬正治:再建術. 新女性医学大系38, 外陰・腟の悪性腫瘍(工藤隆一, 編). 1998;pp130-141, 中山書店, 東京
 
6) Knapstein PG, Friedberg V. Sevin BU:Reconstructive Surgery in Gynecology. pp11-70, Thieme Medical Publishers, New York
 
7) 荻野雅弘, 赤川 元, ほか:外陰癌術後欠損部再建法として大腎筋皮弁を利用した2例. 日本産科婦人科学会雑誌 1988;40:1475-1478
 
8) 塚本直樹:外陰・腟癌手術のコツ. 産婦人科治療 1992;65:656-661
 
9) 杉森 甫, 林 嘉信, 池田雅彦:大腿筋膜張筋皮弁を利用する広汎性外陰切除術. 産婦人科治療 1990;61:1111-1114
 
10) McIndoe AH, Banister JB:An operation for the cure of congenital absence of the vagina. J Obstet Gynaecol Br Comm 1938;45:490-494
 
11) Williams EA:Congenital absence of the vagina, a simple operation for its relief. J Obstet Gynaecol Br Comm 1964;71:511-516
 
12) 塚本直樹, 鶴地伸宏, ほか:腟形成術を行った興味ある4症例. 産婦人科手術 1993;4:82-89
 
13) 楠田雅彦:腟の手術-奇形, 癒着による変形. 現代産科婦人科学大系第13巻C1a, 手術学各論Ia. 1975;pp115-138, 中山書店, 東京
 
14) 塚本直樹:骨盤除臓術. 新女性医学大系34, 子宮頸部の悪性腫瘍(杉森 甫, 編). 2000;pp277-285, 中山書店, 東京
 
15) Smith WG, Johnson GH:Vesicovaginal fistula repair-revisited. Gynecol Oncol 1980;9:303-309
 
16) White AJ, Buchsbaum HJ, et al:Use of bulbocavernosus muscle(Martius procedure)for repair of radiation-induced rectovaginal fistulas. Obstet Gynecol 1982;60:114-118
 
17) 塚本直樹, 中村元一:球海綿体筋を用いた膀胱腟瘻の修復. 産婦人科治療 1987;54:590-594
 
18) 塚本直樹, 嘉村敏治, ほか:放射線治療後直腸腟瘻・膀胱腟瘻. 産婦人科の実際 1992;41:1137-1143
 
19) Hoskins WJ, Park RC, et al:Repair of urinary tract fistulas with bulbocavernosus myocutaneous flaps. Obstet Gynecol 1984;63:588-593
 
20) 塚本直樹, 松隈敬太, ほか:子宮頸癌進行例に対する骨盤除臓術. 産科と婦人科 1987;54:1093-1100
 
P.373 掲載の参考文献
1) 泉 陸一(編訳):内視鏡による婦人科手術学-婦人科および一般外科のための腹腔鏡. 1985, 中央洋書出版部, 東京
 
2) Reddick EJ(ed):Atlas of Laparoscopic Surgery. 1993, Raven Press, New York
 
3) Zucker KA(ed):surgical Laparoscopy update. 1993, QMP, St Louis
 
4) Soderstrom RM(ed):Operative Laparoscopy:The Masters' Techniques. 1993, Raven Press, New York
 
5) Bruhat MA, Mage G, et al:Operative Laparoscopy. 1992, McGraw-Hill, New York
 
6) Phipps JH:Laparoscopic Hysterectomy and Oophorectomy:A Practical Manual and Colour Atlas. 1993, Churchill Livingstone, London
 
7) Padial JG:Operative Laparoscopy for Gynecologists. 1993, IDI Publications, Parthenon Publishing Group, Omaha
 
8) Hulka JF, Reich H:Textbook of Laparoscopy, 2nd ed. 1994, WB Saunders, Philadelphia
 
9) Nezhat CR, Siegler AM:Operative Gynecologic Laparoscopy:Principles and Techniques. 1995, McGraw-Hill, New York
 
10) Gomel V, Taylor PJ(eds):Diagnostic and Operative Gynecologic Laparoscopy. 1995, Mosby, St Louis
 
11) Sutton C, Diamond MP(eds):Endoscopic surgery for Gynecologists, 2nd ed. 1998, WB Saunders, London
 
12) Querleu D, Childers JM, Dargent D(eds):Laparoscopic surgery in Gynaecological Oncology. 1999, Blackwell Science, London
 
13) 伊熊健一郎:卵巣疾患の腹腔鏡下手術-体外法による卵巣嚢腫摘出術を中心として. 1995, メジカルビュー社, 東京
 
14) 堤 治, 伊熊健一郎:入門婦人科腹腔鏡下手術-基本操作・トレーニング・手術の実際(武谷雄二, 監). 1996, メジカルビュー社, 東京
 
15) 伊熊健一郎:実践的腹腔鏡下手術シリーズ-体外法とその応用操作を中心に. 1998, 毎日EVRシステム, 東京
 
16) 伊熊健一郎:実践的腹腔鏡下手術シリーズ-各種疾患に対する体内法での対応. 1998, 毎日EVRシステム, 東京
 
17) 伊熊健一郎:実践的腹腔鏡下手術シリーズ-基本操作と回避すべき対応と対策. 1998, 毎日EVRシステム, 東京
 
18) 伊熊健一郎:実践的腹腔鏡下手術シリーズ-子宮筋腫に対する子宮摘出術. 1999, 毎日EVRシステム, 東京
 
19) 伊熊健一郎:実践的腹腔鏡下手術シリーズ-全腹腔鏡下子宮摘出術. 1999, 毎日EVRシステム, 東京
 
20) 伊熊健一郎:実践的腹腔鏡下手術シリーズ-子宮筋腫に対する筋腫摘出術. 1999, 毎日EVRシステム, 東京
 
21) 伊熊健一郎:実践的腹腔鏡下手術シリーズ-人工造腟術:S状結腸利用法. 1999, 毎日EVRシステム, 東京
 
22) 伊熊健一郎:実践的腹腔鏡下手術シリーズ-人工造腟術:骨盤腹膜利用法から. 1999, 毎日EVRシステム, 東京
 
23) 安藤正明, 伊熊健一郎, ほか:内視鏡による傍大動脈リンパ節郭清-種々の腹膜外到達法とその検討. 産婦人科手術 2000;11:83-91
 
24) 伊熊健一郎:腹腔鏡下手術からのメッセージ-その現況と展望を含めて. 第52回日本産科婦人科学会:生涯研修プログラム. 2000, 毎日EVRシステム, 東京
 
P.389 掲載の参考文献
1) Querleu D, LeBlanc E, Castellain B:Laparoscopic pelvic lymphadenectomy in the staging of early carcinoma of the cervix. Am J Obstet Gynecol 1991;164:579-581
 
2) Childers JM, Hatch K, Surwit A:The role of laparoscopic lymphadenectomy in the management of cervical carcinoma. Gynecol Oncol 1992;47:38-43
 
3) Kavoussi LR, Sosa E, et al:Complications of laparoscopic pelvic lymph node dissection. J Urol 1993;149:322-325
 
4) Burney TL, Campbell EC, et al:Complications of staging laparoscopic pelvic lymphadenectomy. Surg Laparosc Endosc 1993;3:184-190
 
5) Nezhat CR, Nezhat FR, et al:Laparoscopic radical hysterectomy and laparoscopically assisted vaginal radical hysterectomy with pelvic and paraaortic node dissection. Gynecol Surg 1993 9:105-120
 
6) Querleu D:Laparoscopically-assisted radical vaginal hysterectomy. Gynecol Oncol 1993;51:248-254
 
7) Sasaki H, Isonishi S, et al:Acase report of laparoscopic lymphadenectomy with semiradical vaginal hysterectomy for microinvasive carcinomas of the cervix. J Gynecol Tech 1997;3:195-201
 
8) Koonings PP, Campbell K, et al:Relative forequency of primary ovarian neo-plasms:A 10:year review. Obstet Gynecol 1989;74:921-926
 
9) Stein AL, Koonings PP, et al:Relative forequency of malignant parovarian tumors:Should arovarian tumors be aspirated? Obstet Gynecol 1990;75:1029-1031
 
10) Peterson HB, Hulka JF, Phillips JM:American Association of Gynecologic Laparoscopists'1988 membership survey on operative laparoscopy. J Reprod Med 1990;35:587-589
 
11) Parker WH, Berek JS:Management of selected cystic adnexal masses in postmenopausal women by operative laparoscopy:A pilot study. Am, Obstet Gynecol 1990;163:1574-1577
 
12) Lehmann-Willenbrock E, Meck H, Semm K:Preoperative assessment of tumor dignity:A retrospective analysis of 1,016 Ovarian tumors. VII World Congress of Human Reproduction, Helsinki, Finland, June 26 to July 1, 1990a, Abstract 58.
 
13) Lehmann-Willenbrock E, Meck H, Semm K:The treatment of ovarian cysts by operative pelviscopy:A retrospective study of 969 cases. VII World Congress of Human Reproduction, Helsinki, Finland, June 26 to July 1, 1990 b, Abstract 57.
 
14) Hulka JF, Parker WH, et al:Management of ovarian masses. AAG-1990 Survey. J Reprod Med 1992;37:599-602
 
15) 佐藤重美, 蓮尾 豊, ほか:経腟超音波断層法による卵巣癌の集団検診-要二次検診とすべき卵巣の大きさについて. 日本産科婦人科学会雑誌 1992;44:1173-1179
 
16) 佐々木 寛, 寺島芳輝:予後因子からみた術式の選択. 産婦人科の実際 1989;38:689-695
 
17) Colombo N, Chiari S, et al:Controversial issues in the management of early epithelial ovarian cancer:Conservative surgery and role of adjuvant therapy. Gynecol Oncol 1994;55:S47-S51
 
18) 田中忠夫:平成8年度がん克服新10か年戦略プロジェクト研究報告書. 1997, 厚生省, 東京
 
19) Dembo AJ, Davy M, et al:Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990;75:263-273
 
20) Kodama S, Tanaka K, et al:Multivariate analysis of prognostic factors in patients with ovarian cancer stage I and II, Int J Gynaecol Obstet 1997;56:147-153
 
21) LaGrenade A, Silverberg SG:Ovarian tumors associated with atypical endometriosis. Hum Pathol 1988;19:1080-1084
 
22) Corner GW Jr, Hu C-Y, Hertig AT:Ovarian carcinoma arising in endometriosis. Am J Obstet Gynecol 1950;59:760
 
23) Mostoufizadeh M, Scully RE:Malignant tumors arising in endometriosis. Clin Obstet Gynecol 1980;23:951-963
 
24) 佐々木 寛, 多田聖郎, 寺島芳輝:卵巣境界悪性腫瘍群の取り扱い. 産科と婦人科 1991;58:790-799
 
25) 佐々木 寛, 寺島芳輝:泌尿生殖器腫瘍における化学療法時の予後因子, 卵巣腫瘍における化学療法時の予後因子. Oncology & Chemotherapy 1991;7:267-273
 
26) Sasaki H, Furusato M, et al:Prognostic significance of histopathological subtypes in stage I pure yolk sac tumour of the ovary. Br J Cancer 1994;69:529-536
 
27) Panici PB, Maneschi F, et al:Lymphatic spread ofcervical cancer:An anatomical and pathological study based on 225 radical hysterectomies with systemic pelvic and aortic lymphadenectomy. Gynecol Oncol 1996;62:19-24
 
28) Onda T, Yoshikawa H, et al:Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy., Br J Cancer 1997;75:1836-1841
 
29) Possover M, Krause N, et al:Laparoscopic assistance for extended radicality of radical vaginal hysterectomy:Discription of a technique. Gynecol Oncol 1998;70:94-99
 
30) Nezhat C, Nezhat F, et al:The role of laparoscopy in the management of gynecologic malignancy. Semin Surg Oncol 1994;10:431-439
 
31) Childers JM, Brzechfora PR, et al:Laparoscopically assisted surgical staging(LASS)of endometrial cancer. Gynecol Oncol 1993;51:33-38
 
32) 山田英夫, 松本康久, ほか:後腹膜腔鏡による鏡視下手術. 手術 1998;52:555-561
 
33) 安藤正明, 伊熊健一郎, ほか:内視鏡による傍大動脈リンパ節郭清, 種々の腹膜外到達法とその検討. 産婦人科手術 2000;11:83-91
 
34) Hacker NF, Wain GV, Nicklin JL:Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995;5:250-256
 
35) 佐々木 寛, 新美茂樹, ほか:腹腔鏡下骨盤内リンパ節郭清術. 産婦人科手術 1998;9:81-90
 
36) Bouvy ND, Marquet RL, et al:Impact of gas(less)laparoscopy and laparotomy on peritoneal tumor growth and abdominal wall metastases. Ann Surg 1996;224:694-700
 
37) Watson DI, Mathew G, et al:Gasless laparoscopy may reduce the risk of portsite metastases following laparoscopic tumor surgery. Arch Surg 1997;132:166-168
 
38) Childers JM, Hatch KD, et al:Laparoscopic para-aortic lymphadenectomy in gynecologic malignancies. Obstet Gynecol 1993;82:741-747
 
39) Querleu D, LeBlanc E:Laparoscopic inforarenal paraaortic lymph node dissection for restaging of carcinoma of the ovary or fallopian tube. Cancer 1994;73:1467-1471
PubMed
40) Spirtos NM, Schlaerth JB, et al:Laparoscopic radical hysterectomy(Type III)with aortic and pelvic lymphadenectomy. !Am J Obstet Gynecol 1996;174:1763-1767
 
41) Chu KK, Chang SD, et al:Laparoscopic surgical staging in cervical cancer:Preliminary experience among Chinese. Gynecol Oncol 1997;64:49-53
 
42) 安藤正明, 伊熊健一郎, ほか:内視鏡による傍大動脈リンパ節郭清-種々の腹膜外到達法とその検討. 産婦人科手術 2000;11:83-91
 
43) Dargent D, Mathevet P:Radical laparoscopic vaginal hysterectomy. J Gynecol Obstet Biol Reprod (Paris) 1992;21:709-710
 
44) Dargent D:Laparoscopic surgery and gynecologic cancer. Curr Opin Obstet Gynecol 1993;5:294-300
 
45) Dargent DFG, Mathevet P:Radical vaginal hysterectomy in the primary treatment of invasive cervical cancer, Cervical Cancer and Preinvasive Neoplasia(Rubin SC, Hoskins WJ, eds). 1996;pp207-217, Lippincott-Raven, Philadelphia
 
46) 海老原敏, 佐々木 寛:がん患者のQOLに関する研究, 機能温存する外科療法に関する研究, 平成11年度がん克服新10か年戦略プロジェクト研究報告書. 2000, 厚生省, 東京
 
P.409 掲載の参考文献
1) 福島亮治, 齊藤英昭:Mucosal barrier bacterial translocation. 消化器外科 1996;19:1849-1857
 
2) 田中宣威, 恩田昌彦, ほか:イレウスの原因と病態生理. 消化器外科 1996;19:1787-1792
 
3) 早坂 滉, 秋山守文:成因別にみたイレウスの治療方針と全身管理. 消化器外科 1987;10:1531-1538
 
4) 疋田茂樹, 掛川暉夫, 溝手博義:術後イレウスの手術とそのタイミング. 消化器外科 1991;14:1647-1656
 
5) 徳原 真, 羽木裕雄, ほか:イレウスの画像診断. 消化器外科 1996;19:1793-1801
 
6) Baker SR:The Abdominal Plain Film. 1990;pp155-242, Appleton & Lange, Norwalk
 
7) Mucha P:Small intestinal obstruction, Surg Clin North Am 1987;67:597-620
 
8) 永井 純, 築根吉彦, ほか:イレウスの画像診断. 消化器外科 1987;10:1523-1530
 
9) 四方淳一:イレウスの治療方針:特に術後癒着性イレウスを中心として. 日本臨床外科医学会雑誌 1978;39:453-456
 
10) 小林一雄, 吉雄敏文:術後イレウス:術後早期の機械的イレウスについて. 外科治療 1999;80 (増刊):1072-1075
 
11) 中野博重, 藤井久男:腸管運動麻痺・麻痺性イレウス. 消化器外科 1994;17(臨時増刊):874-875
 
12) 谷 一郎, 新美 浩, ほか:急性腹症・外傷のCT診断. 消化器外科 1999;22:999-1011
 
13) Megibow AJ, Balthazar EJ, et al:Bowel obstruction:Evaluation with CT. Radiology 1991;180:313-318
 
14) Balthazar EJ I George W Holmes Lecture. CT of small-bowel obstruction. AJR Am J Roentgenol 1994;162:255-261
 
15) Frager D, Medwid SW, et al:CT of small-bowel obstruction:Value in establishing the diagnosis and determining the degree and cause. AJR Am J Roentogenol 1994;162:37-41
 
16) Ha HK, Park CH, et al:CT analysis of intestinal obstruction due to adhesions:Early detection of strangulation. JConlput Assist Tonlogr 1993;17:386-389
 
17) 高崎秀明, 恩田昌彦:腸閉塞. 消化器外科 1999;22:1109-1114
 
18) 継 行男, 川村邦昭:イレウスの診断と治療[I]. 外科治療 1987;57:302-312
 
19) 継 行男, 川村邦昭, ほか:イレウスの保存的治療法とその限界. 外科治療 1991;64:434-442
 
20) 疋田茂樹, 溝手博義, 白水和雄:術後早期イレウスの治療方針. 消化器外科 1996;19:1811-1818
 
21) 加藤博久, 村上雅彦, ほか:術後癒着イレウスに対するチューブ療法の経験. 日本臨床外科医学会雑誌 1995;56:16-21
 
22) 布施 暁, 八木義弘:癒着性イレウスに対する保存的治療と手術適応. 消化器外科 1996;19:1803-1809
 
23) 馬場正三, 佐藤滋美:イレウス手術の時期と手術法. 消化器外科 1987;10:1551-1556
 
24) 恩田昌彦, 森山雄吉, ほか:イレウスに対する保存的療法の限界. 消化器外科 1987;10:1539-1548
 
25) 沖永功太, 安達実樹:イレウスの手術的療法と術前処置. 外科治療 1991;64:443-451
 
26) 継 行男, 川村邦昭:イレウスの診断と治療[II]. 外科治療 1987;57:438-443
 
27) 横山滋彦, 恩田昌彦, ほか:イレウスの治療方針の決定におけるradiopaque markerの有用性. 日本外科学会雑誌 1994;95:326-335
 
28) 四方淳一, 三重野寛治, ほか:イレウス総論. 新外科学大系25B, 腹壁・腹膜・イレウスの外科II(出月康夫, 川島康生, ほか編). 1990;pp205-247, 中山書店, 東京
 
29) Cooperman M, Martin EW, et al:Use of doppler ultrasound in intestinal surgery. Am J Surg 1979;138:856-859
 
30) 天野 洋, Hamilton SR, Bulkley GB:フローレッセン蛍光法による虚血腸管の予後の判定に関する実験的研究. 日本外科学会雑誌 1984;85:56-64
 
31) Stolar CJ, Randolph JG:Evaluation of ischemic bowel viability with a fluorescent technique. J Pediatr Surg 1978;13:221-225
 
32) Bulkley GB, Zuidema G, et al:lntraoperative determination of small intestinal viability following ischemic injury. Ann Surg 1981;193:628-637
 
33) Carter MS, Fantini GA, et al:Qualitative and quantitative. Am J Surg 1984;147:117-123
 
34) Bussemaker JB, Linderman J:Comparison of methods to determine viability of small Intestine. Ann Surg 1972;176:97-101
 
35) 恩田昌彦, 森山雄吉, ほか:腸閉塞. 外科治療 1986;55:748-756
 
36) 阪口周吉:腹部大動脈瘤手術に伴う腸管阻血の予防に関する研究. 昭和58年度科学研究費補助金一般研究C研究成果報告書.
 
37) 星合 昊, 澤井 猛, ほか:産婦人科領域における術後癒着防止材セプラフィルム(TM)の臨床的検討. 産科と婦人科 1998;65:803-812
 
38) 藤下 晃, 蓮尾敦子, 石丸忠之:子宮筋腫核出術後の癒着防止対策. 産婦人科治療 1999;78:1086-1090
 
39) 吉田信隆, 工藤尚文:術後癒着防止の工夫. 産婦人科治療 1997;74:496-499
 
40) 山岡郁雄, 松峯敬夫, 浮島仁也:腹腔内ステロイド投与の効果. 日本臨床外科医学会雑誌 1978;39:469-473
 
41) 矢野博道, 溝手博義, ほか:コンドロイチン硫酸, トラジロール, ウロキナーゼ剤の応用. 日本臨床外科医学会雑誌 1978;39:473-477
 
42) White RR:Prevention of recurrent small bowel obstruction due to adhesions. Ann Surg 1956;143:714-719
 
43) 山本修三:Intestinal splinting法. 臨床外科 1973;28:1281-1287
 
44) 木村秀幸:Nobleの手術, 再発予防について. 日本臨床外科医学会雑誌 1978;39:55-58
 
45) 田中豊治, 吉野肇一:T式シートを用いた癒着性イレウスの治療. 消化器外科 1996;19:1819-1829
 
46) 神田達夫, 中村茂樹, 畠山勝義:術後腸蠕動障害. 外科治療 1999;80(増刊):423-425
 
47) 山口俊晴, 高橋俊雄, ほか:癌性腹膜炎・癌性イレウスの治療. 日本外科学会雑誌 1999;100:211-215
 
48) 加古博史, 小川道雄:イレウス管の挿入法. 外科治療 1991;64:744-746
 
49) 小野寺久, 朴 泰範, ほか:放射線腸炎の病態と外科治療法. 日本消化器病学会雑誌 1993;26:2803-2808
 
50) 山田一隆, 島津久明:放射線腸炎, この症例の検査, 診断と治療方針. 外科 1988;50:744-748
 
51) Roswit B, Malsky SJ, Reid CB:Severe radiation injuries of the stomach, small intestine, colon and rectum. Am J Roentgenol Radium Ther Nucl Med 1972;114:460-475
 
52) Marks G, Mohiudden M:The surgical management of the radiation injured intestine. Surg Clin North Am 1983;63:81-96
 
53) Todd TF:Rectal ulceration following irradiation treatment of carcinoma of the cervix uteri. Surg Gynecol Obstet 1938;67;617-631
 
54) Allen-Mersh TG, Wilson EJ, et al:The management of late radiation-induced rectal injury after treatment of carcinoma of the uterus. Surg Gynecol Obstet 1987;164:521-524
 
55) 戸塚守夫, 佐々木一晃:放射線腸炎. 外科 1988;50:749-754
 
56) Swan RW, Fowler WC, et al:Surgical management of radiation injury to the small intestine. Surg Gynecol Obstet 1976;142:325-327
 
57) Sherman L:A reevaluation of the factitial proctitis problem. Am J Surg 1954;88:773-779
 
58) Parks AG, Allen CLO, et al:Amethod of treating post-irradiation rectovaginal fistulas. Br J Surg 1978;65:417-421
 
59) 田中承男, 内藤和世, ほか:放射線腸管障害の手術経験. 日本臨床外科医学会雑誌 1983;44:112-117
 
60) 壬生隆一, 大畑佳裕, ほか:直腸腟瘻を伴った放射線性直腸炎に対する結腸肛門吻合術. 手術 1998;52:915-918
 
61) 中島俊一, 石井俊也, ほか:エタノール局注止血が有効であった放射線照射性腸炎の1例. 消化器内視鏡の進歩 1993;43:221-223
 
62) 成松昭夫, 岡田 理, 片山 節:動脈塞栓術にて救命しえた放射線大腸炎による大量下血の1例. 産科と婦人科 1995;62:1633-1636
 
63) Cormio G, Vango G, et al:Surgical treatment of recurrent ovarian cancer:Report of 21 cases and areview of the literature. Eur J Obstet Gynecol Reprod. Biol 1999;86:185-188
 
64) 掛地吉弘, 蓮田正太, 杉町圭蔵:腸管の縫合と吻合, 漿膜接合型. 消化器外科 1998;21:67-71
 
65) 丸山圭一:Gambee 1層吻合法の利点と部位によるtechnical variation. 日本外科学会雑誌 1979;80:1150-1154
 
66)澤田俊夫, 洲之内広紀, 武藤徹一郎:小腸・大腸吻合術における器械吻合法の手技と留意点. 手術 1993;47:1008-1015
 
67) 徳永恵子:ストーマの位置決定. ストマケア基礎と実際(ストマリハビリテーション講習会実行委員会, 編). 1985;pp141-147, 金原出版, 東京
 
68) 山口正康:PEGによる経腸栄養管理. 日本醫事新報 2000;3965:36-41
 
P.428 掲載の参考文献
1) Doran J, Roberts M:Acute urinary retention in the female. Br J Urol 1975;47:793-796
 
2) Stovsky MD, Ignatoff JM, et al:Use of electrocoagulation in the treatment of vesicovaginal fistulas. J Urol 1994;152:1443-1444
 
3) Ueda T, Iwatsubo E, et al:Closure of vesicovaginal fistula using vaginal flap. J Urol 1978;119:742-743
 
4) O'Conor VJ Jr:Review of experience with vesicovaginal fistula repair. J Urol 1980;123:367-369
 
5) Warwick RT, Worth PH:The psoas bladder-hitch procedure for the replacement of the lower third of the ureter. Br J Urol 1969;41:701-709
 
6) Greenstein A, Vernon Smith MJ:Surgery of the ureter. Campbelrs Urology (Walsh PC, Retik AB, et al, eds), 6th ed. 1992;pp2565-2566, WB Saunders, Philadelphia
 
7) Higgins CC:Ureteral injuries during surgery. A review of 87 cases. JAMA 1967;199:82-88
 
8) McGuire EJ, Weiss RM, et al:Hemorrhagic radiation cystitis:Treatment. Urology 1974;3:204-208
 
9) Duncan w, Quilty PM:The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage x-ray therapy. Radiother Oncol 1986;7:299-310
 
10) Norkool DM, Hampson NB, et al:Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. J Urol 1993;150:332-334
 
11) Dean RJ, Lytton B:Urologic complications of pelvic irradiation. J Urol 1978;119:64-67
 
12) Ram MD:Complications of radiotherapy for carcinoma of the bladder. Proc R Soc Med 1970;63:93-95
 
13) Ravi R:Endoscopic neodymium:YAG laser treatment of radiation-induced hemorrhagic cystitis. Lasers Surg Med 1994;14:83-87
 
14) Pourquier H, Delard R, et al:Aquantified approach to the analysis and prevention of urinary Complications in radiotherapeutic treatment of Cancer Of the Cervix. Int J Radiat Oncol Biol Phys 1987;13:1025-1033
 
15) Montana GS, Fowler WC:Carcinoma of cervix:Analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys 1989;16:95-100
 
16) Orton CG, Wolf-Rosenblum S:Dose dependence of complication rates in cervix cancer radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:37-44
 
17) de Vries CR, Freiha FS:Hemorrhagic cystitis:A review. J Urol 1990;143:1-9
 
18) Marx RE:Anew concept in the treatment of osteoradionecrosis. J Oral faxillofac Surg 1983;41:351-357
 
19) 宮里朝矩, 湯佐祚子, ほか:放射線性出血性膀胱炎に対する高気圧酸素治療の臨床的検討. 日本泌尿器科学会雑誌 1998;89:552-556
 
20) 河本寛治, 野口純雄, ほか:放射線性膀胱炎の臨床的観察. 泌尿器科紀要 1992;38:395-398
 
21) 鈴木孝憲, 小野芳啓, ほか:照射方法と周辺臓器被曝-膀胱直腸障害対策. 泌尿器外科 1999;12:977-981
 
22) Goswami AK, Mahajan RK, et al:How safe is 1% alum irrigation in controlling intractable vesical hemorrhage? J Urol 1993;149:264-267
 
23) Ostroff EB, Chenault OW:Alum irrigation for the control of massive bladder hemorrhage. J Urol 1982;128:929-930
 
24) Singh I, Laungani GB:Intravesical epsilon aminocaproic acid in management of intractable bladder hemorrhage. Urology 1992;40:227-229
 
25) Mitcheson DH, Schiff M:Urinary tract bleeding. Diagnosis and control by medical, radiological and surgical techniques. Management of lntractable Bladder Hemorrhage(Bern MM, ed). 1985;pp241-266, Futura, New York
 
26) Donahue LA, Frank IN:Intravesical formalin for hemorrhagic cystitis:Analysis of therapy. J Urol 1989;141:809-812
 
27) Lowe BA, Stamey TA:Endoscopic topical placement of formalin soaked pledgets to control localization hemorrhage due to radiation cystitis. J Urol 1997;158:528-529
 
28) 西村憲二, 目黒則男, ほか:膀胱内ホルマリン注入によるショックの一例. 泌尿器科紀要 1992;38:841-843
 
29) Dewan AK, Madan G, Ravi R:Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix. Int J Gynaecol Obstet 1993;42:131-135
 
30) Weiss JP, Boland FP, et al:Treatment of radiation-induced cystitis with hyperbaric oxygen. J Oncol 1985;134:352-354
 
31) Bevers RFM, Bakker DJ, Kurth KH:Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. Lancet 1995;346:803-805
 
32) Weiss JP, Mattei DM, et al:Primary treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen:10-year experience. J Urol 1994;151:1514-1517
 
33) Pizzo JJD, Chew BH, et al:Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen Long-term followup. J Urol 1998;160:731-733
 
34) Lang EK, Deutsch JS, et al:Transcatheter embolization of hypogastric branch arteries in the management of intractable bladder hemorrhage. J Urol 1979;121:30-36
 

書評

最近チェックした商品履歴

Loading...